Bharat Book Bureau

As a result of the growing population of the elderly, healthcare systems are challenged to treat rising incidences of complex diseases and conditions. Emerging wound care products and technologies are well-positioned to capitalize on this growth.

These advanced wound care products are detailed in Wound Care 2010, our complete look at the wound care industry. As part of its coverage of the market in 2010, this report includes:

Market Size and Forecast

Key Industry Developments and Trends

Review of Major Products

Company Profiles

Types of Wounds and Treatment

Market by Application Area (Burns, Skin Ulcers, Surgical and Trauma Wounds)

Market by Product Categories (Closures, Anti-Infectives, Dressings, Cleaning/Debridement, Other)

Regional Breakout of Market (US, Europe, Asia, ROW)

Competitive Analysis and Market Share

Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes.

The worldwide wound care market is based on total manufacturers’ revenues. The information and analysis presented in this report are based on extensive surveys of senior management in the wound care market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct over 60 interviews with industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.

As part of the coverage in this report, the following companies are profiled:

3M Healthcare

Advanced BioHealing

Baxter BioScience

Covidien, Ltd.

Covatech

Derma Sciences

Glaxo Smith Kline

Healthpoint

Hill-Rom

Johnson & Johnson

Kinetic Concepts

Medline Industries

MoInlycke Healthcare

Pfizer

Smith & Nephew

Systagenix Wound Management

All market data pertains to the U.S. market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2009. Historical data are provided for each of the years 2007 through 2009, and forecast data are provided for each of the years 2009 through 2014. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2009 base year.

Table of Contents:

CHAPTER ONE: EXECUTIVE SUMMARY
Introduction
Scope and Methodology
Size and Growth of the Market
Trends Affecting the Market
Competitive Outlook

CHAPTER TWO: INTRODUCTION AND OVERVIEW
Functions of Skin
Normal Integument

Epidermis
Dermis
Subcutaneous Tissue

Effects of Aging on the Integumentary System
Types of Wound Healing
Wound Healing Process
Delays of Wound Healing
Complications of Wound Healing

Hypertrophic Scars and Keloid Formation
Contracture
Dehiscence
Excess Granulation Tissue
Adhesions

CHAPTER THREE: MAIN TYPES OF WOUNDS
Skin Ulcers

Pressure or Decubitus Ulcers
Diabetic Ulcers or Neuropathic Ulcers
Arterial Ulcers
Venous Ulcers

Burns

Thermal Injury
Chemical Injury
Electrical Injury
Depth Classification

First-Degree Burns
Superficial Partial-Thickness Burns (Second-Degree)
Deep Partial Thickness Burns
Full-Thickness Burns (Third and Fourth-Degree)

SURGICAL WOUNDS
Trauma Wounds

CHAPTER FOUR: PRODUCTS
Anti-Infectives

Industry Innovations

Compression and Composite Dressings

Industry Innovations

Sutures

Absorbable

Surgical Gut

Synthetic Absorbable Polymers
Nonabsorbable
Surgical Silk
Surgical Cotton
Linen
Surgical Stainless Steel
Synthetic Nonabsorbable Polymers

Staplers and Staples
Tissue Adhesives, Sealants and Glues

Fibrin-based
Collagen-based V
Polymeric Sealants
Synthetic Adhesives/Glues

Tapes
Dry Dressings

Industry Innovations

Cleansing

Debridement
Industry Innovations

Alginates

Industry Innovations

Hydrocolloids
Hydrogels

Industry Innovations

Films

Industry Innovations

Foam Dressings

Industry Innovations

Artificial Skin

Industry Innovations

Collagen

Industry Innovations

Growth Factors
Negative Pressure Wound Therapy

Industry Innovations

Pressure Relief

Industry Innovations

Miscellaneous

Electrical Stimulation
Ultraviolet
Oxygen and Hyperbaric Oxygen
Whirlpool Therapy
Electromagnetic Therapy Device
Ultrasound
Low Intensity Laser Therapy
Other Therapies
Industry Innovations

CHAPTER FIVE: TOTAL MARKET SIZE, FORECAST AND COMPETITIVE ANALYSIS
Total Market by Application Area
Total Market by Product Category
Total Market by Region
Competitive Market Summary

CHAPTER SIX: INDUSTRY DEVELOPMENTS
Demographics and Epidemiology
Scars
Honey Treatment
Reimbursement

Reimbursement Developments

Electronic Medical Records
Telemedicine and Wound Care
Regulatory Issues
Non-Payment Events
Evidence-Based Wound Care
Silver Toxicity
Home Care
Wound Care Clinics

CHAPTER SEVEN: COMPANY PROFILES
Overview
3M Healthcare
Advanced Bio Healing
Baxter BioScience
Convatech
Covidien, Ltd.
Derma Sciences
Glaxo Smith Kline
Healthpoint
Hill-Rom
Johnson & Johnson
Kinetic Concepts
Medline Industries
MoInlycke Healthcare
Pfizer
Smith & Nephew
Systagenix Wound Management

For more please visit
http://www.bharatbook.com/detail.asp?id=141449&rt=World-Wound-Care-Markets-2010.html

OR Contact us at
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com

This report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report details current clinical and technology developments in this huge worldwide market with high growth sectors, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

The report provides full year (actual) 2008 market size and share data, with forecast market data to 2017, for the U.S., Europe, Asia/Pacific and Rest of World.

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments — multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying the huge and evolving worldwide wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced wound care research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Table of Contents:

EXECUTIVE SUMMARY
Acute Wounds
Burns
Chronic Wounds
Products Used in Advanced Wound Management
Film Dressings
Hydrocolloid Dressings
Foam Dressings
Alginate Dressings
Hydrogels
Non-Adherent Dressings
Anti-Microbial Dressings
Wound Cleansers and Debriding Agents
Skin Replacements and Substitutes
Pharmacological Products
Physical Therapies
The Market
The Industry

SECTION 1: BACKGROUND
1.1 Industry Structure
1.2 A Complex Industry
1.3 Major Wound Management Corporations
1.4 Historical Perspective and Technology Breakthroughs
1.5 Worldwide Regulatory and Reimbursement Environment
1.5.1 Cost Effectiveness
1.5.2 Clinical
1.5.3 Regulatory
1.5.4 Reimbursement
1.5.4.1 U.S.A
1.5.4.2 European Union
1.5.4.3 France
1.5.4.4 Germany
1.5.4.5 United Kingdom .
1.5.4.6 Italy
1.5.4.7 Belgium
1.5.4.8 Spain
1.5.4.9 Scandinavia.
1.6 Geographical Differences in Treatments of Wounds
1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
1.8 Wound Management Trends
1.8.1 Surgical Wounds
1.8.2 Traumatic Wounds
1.8.3 Burns
1.8.4 Chronic Wounds
1.9 Market Dynamics

SECTION 2: CLINICAL BACKGROUND AND CASELOAD
2.1 Background
2.1.1 A Few Figures
2.1.2 Overview of Functions
2.1.3 Skin Anatomy: A Summary
2.2 Types of Wounds
2.2.1 Classification By Severity
2.2.2 Classification By Morphology
2.2.3 Classification By Etiology
2.2.4 Color Classification
2.3 Surgical Wounds
2.4 Traumatic Wounds
2.5 Burns
2.5.1 Debridement
2.5.2 Grafting
2.6 Pressure Ulcers
2.6.1 Ulcer Classification
2.6.2 Hospital-Acquired Ulcers
2.6.3 Management of Pressure Ulcers
2.7 Venous Ulcers
2.8 Arterial Ulcers
2.9 Diabetic Ulcers
2.9.1 Prevalence
2.9.2 Stages of Diabetic Ulcer
2.9.3 Treatment
2.9.3.1 Amputations
2.9.3.2 Abnormal Scarring
2.9.4 Acquired Immunodeficiency Syndrome
2.10 Wound Healing Physiology
2.10.1 Inflammatory Phase
2.10.2 Proliferative Phase
2.10.2.1 Angiogenesis
2.10.3 Maturation Phase
2.11 Factors Affecting Wound Healing
2.11.1 Extrinsic Factors
2.11.2 Mechanical Stress
2.11.3 Debris
2.11.4 Temperature
2.11.5 Desiccation and Maceration
2.11.6 Infection
2.11.7 Chemical Stress
2.11.8 Medication
2.11.9 Other Extrinsic Factors
2.11.10 Intrinsic Factors
2.11.11 Health Status
2.11.12 Age Factors
2.11.13 Body Build
2.11.14 Nutritional Status
2.12 Major Treatment Categories and Regimes
2.13 Incidence of Treatments, Growth Rates and Trends

SECTION 3: PRODUCTS, TECHNOLOGIES AND MARKETS
3.1 Background
3.2 Film Dressings
3.2.1 Overview
3.2.2 Product Examples
3.2.3 Market and Competitive Activity
3.3 Hydrocolloids
3.3.1 Overview
3.3.2 Product Examples
3.3.3 Market and Competitive Activity
3.4 Foam Dressings
3.4.1 Overview
3.4.2 Product Examples
3.4.3 Market and Competitive Activity
3.5 Alginate Dressings
3.5.1 Overview
3.5.2 Product Examples
3.5.3 Market and Competitive Activity
3.6 Hydrogels
3.6.1 Overview
3.6.2 Product Examples
3.6.3 Market and Competitive Activity
3.7 Non-Adherent Dressings
3.7.1 Overview
3.7.2 Product Examples
3.7.3 Market and Competitive Activity
3.8 Antimicrobial Dressings
3.8.1 Overview
3.8.2 Product Examples
3.8.3 Market and Competitive Activity
3.9 Tissue-Engineered Products
3.9.1 Overview
3.9.2 Traditional Skin Grafts
3.9.3 Skin Replacements
3.9.4 Product Examples
3.9.5 Market and Competitive Analysis
3.10 Pharmacological Products
3.10.1 Overview
3.10.2 Product Examples
3.10.2.1 Growth Factors
3.10.2.2 Growth Factors: Background.
3.10.2.3 Classification
3.10.2.4 Other Growth Factors
3.10.2.5 Non-Growth Factor Modulators
3.10.3 Market and Competitive Analysis
3.10.3.1 Growth Factors
3.10.3.2 Non-Growth Factor Stimulants
3.10.3.3 Gene Therapy
3.11 Physical Treatments
3.11.1 Negative Pressure Devices
3.11.2 Positive Pressure Devices
3.11.3 Mechanically Assisted Wound Closure
3.11.4 Other Physical Wound Therapies
3.11.4.1 Hydrotherapy
3.11.4.2 Electrical Stimulation
3.11.4.3 Electromagnetic Stimulation Devices
3.11.4.4 Ultraviolet Therapy
3.11.4.5 Hyperbaric Oxygen Therapy
3.11.4.6 Ultrasound Devices
3.11.4.7 Laser Devices
3.11.4.8 Wound Imaging/Documentation
3.11.5 Market and Competitive Analysis..
3.11.5.1 Pressure Relief Devices.
3.11.5.2 Hydrotherapy
3.11.5.3 Electrical Stimulation
3.11.5.4 Hyperbaric Oxygen Therapy

SECTION 4: COUNTRY MARKET ANALYSIS
4.1 Global Overview
4.2 Market Estimates
4.2.1 Market Potential
4.2.2 Leading Wound Care Companies
4.2.3 Leading National Markets
4.3 United States
4.3.1 Market Opportunity.
4.3.2 Market for Advanced Wound Management Products
4.4 Japan
4.4.1 Wound Care Market
4.4.2 Market Opportunity
4.4.3 Leading Companies
4.5 Germany
4.5.1 Wound Care Market
4.5.2 Leading Companies.
4.6 France
4.6.1 Wound Care Market
4.6.2 Leading Companies.
4.7 Italy
4.7.1 Wound Care Market
4.7.2 Leading Companies.
4.8 United Kingdom
4.8.1 Wound Care Market
4.8.2 Leading Companies

SECTION 5: COMPANY PROFILES
5.1 Major Companies
5.1.1 3M Health Care
5.1.2 B. Braun Melsungen AG
5.1.3 Coloplast Group
5.1.3.1 Financials
5.1.4 ConvaTec Inc.
5.1.5 Covidien
5.1.5.1 Kendall
5.1.6 Derma Sciences, Inc.
5.1.7 DeRoyal Industries Inc.
5.1.8 Ethicon (Johnson & Johnson)
5.1.9 Gentell Inc.
5.110 Geritrex Corp
5.1.11 Hartmann Group
5.1.12 Hollister Incorporated
5.1.13 Lohmann & Rauscher International GmbH and Co. KG
5.1.14 Medline Industries
5.1.15 Mölnlycke Health Care AB
5.1.16 Smith & Nephew plc
5.1.17 Systagenix Wound Management (US), Inc.
5.1.18 UDL Laboratories
5.2 Specialist Companies
5.2.1 Antimicrobial Dressings
5.2.1.1 AcryMed Inc.
5.2.1.2 Argentum Products LLC
5.2.1.3 Microban International Ltd
5.2.2 Oxygen Therapy
5.2.2.1 Perry Baromedical
5.2.3 Tissue Regeneration
5.2.3.1 Perry Baromedical
5.2.3.2 Celltran Limited
5.2.3.3 Euroderm AG
5.2.3.4 Fidia Advanced Biopolymers
5.2.3.5 Forticell Bioscience, Inc.
5.2.3.6 Genzyme Biosurgery
5.2.3.7 Integra LifeSciences Inc.
5.2.3.8 Organogenesis Inc.
5.2.3.9 Kinetic Concepts Inc.
5.2.3.9.1 LifeCell Corporation
5.2.4 Growth Factors
5.2.4.1 ES Cell International
5.2.5 Electrical Therapies
5.2.5.1 BioMedical Life Systems, Inc.
5.2.5.2 Diapulse Corporation of America
5.2.5.3 Electromedical Products International Inc.
5.2.5.4 Koldcare
5.2.5.5 Microvas Technologies
5.2.6 Odor Control
5.2.6.1 CliniMed
5.2.7 Other Therapeutic Modalities
5.2.7.1 AGT Sciences Ltd
5.2.7.2 Agennix
5.2.7.3 Advanced Medical Solutions Group plc
5.2.7.4 Anodyne Therapy LLC
5.2.7.5 Applied Tissue Technologies
5.2.7.6 Regenesis Biomedical Inc.
5.2.7.7 Roho Inc.
5.2.7.8 Uluru, Inc.
5.2.8 Summary Profiles
5.2.8.1 AciesHealth
5.2.8.2 Bard Medical Division
5.2.8.3 Brennen Medical Inc.
5.2.8.4 BSN medical Ltd
5.2.8.5 Celleration, Inc.
5.2.8.6 DermaRite Industries LLC
5.2.8.7 Ferris Manufacturing Corp.
5.2.8.8 Fibrogen
5.2.8.9 Geistlich Pharma.
5.2.8.10 Healthpoint
5.2.8.11 HemCon Medical Technologies
5.2.8.12 Human BioSciences, Inc.
5.2.8.13 Hymed Group Corporation
5.2.8.14 Innocol, Inc.
5.2.8.15 Laboratoires Urgo
5.2.8.16 LifeWave Ltd
5.2.8.17 Longport Inc.
5.2.8.18 MPM Medical
5.2.8.19 Nagor Ltd
5.2.8.20 Oculus Innovative Sciences, Inc.
5.2.8.21 Pioneer Surgical Technology, Inc.
5.2.8.22 Unomedical
5.2.8.23 Swiss American Products, Inc.
5.2.8.23.1 Wound Care Products
5.2.8.24 Wound Care Innovations, LLC
APPENDIX: LIST OF COMPANIES

List of Exhibits

Exhibit ES-1: Advanced Wound Care Market, by Segment, 2008 & 2017
Exihbit ES-2: Advanced Wound Care Market Shares by Competitor, 2008

Exhibit 1-1: Worldwide Wound Prevalence by Etiology, 2008
Exhibit 1-2: Advanced Wound Management, Worldwide Market Forecast, 2008–2017
Exhibit 1-3: Total World Wound Management Products, Market Forecast, 2008–2017

Exhibit 2-1: Classification of Wounds by Etiology
Exhibit 2-2: Old and New Classification Systems for Burns
Exhibit 2-3: Distribution of Pressure Ulcers

Exhibit 3-1: Companies and Products in the Film Dressings Category
Exhibit 3-2: Film Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-3: Film Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-4: Companies and Products in the Hydrocolloid Dressings Category
Exhibit 3-5: Hydrocolloid Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-6: Hydrocolloid Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-7: Leading Companies and Products in the Foam Dressings Category
Exhibit 3-8: Foam Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-9: Foam Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-10: Companies and Products in the Alginate Dressings Category
Exhibit 3-11: Alginate Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-12: Alginate Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-13: Amorphous Hydrogels – Companies and Products
Exhibit 3-14: Impregnated Hydrogels – Companies and Products
Exhibit 3-15: Sheet Hydrogels, Companies and Products
Exhibit 3-16: Hydrogel Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-17: Hydrogel Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-18: Companies and Products in the Non-Adherent Dressings Category
Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-21: Companies and Products in the Antimicrobial Dressings Category
Exhibit 3-22: Antimicrobial Dressings, Worldwide Market Forecast, 2008-2017
Exhibit 3-23: Antimicrobial Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-24: Companies and Products in the Tissue Engineering Category
Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2008–2017
Exhibit 3-26: Tissue Engineering, Worldwide Share by Supplier, 2007, 2008
Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2008–2017
Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category
Exhibit 3-29: Physical Wound Therapies, Worldwide Market Forecast, 2008–2017

Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2008–2017
Exhibit 4-2: Leading Global Wound Care Companies by Market Share
Exhibit 4-3: Leading Global Wound Care Companies, Market Share, 2008
Exhibit 4-4: National Shares of the Global Advanced Wound Management Market, 2008
Exhibit 4-5: Forecast U.S. Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-6: Forecast U.S. Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-7: Japanese Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-8: Japanese Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-9: German Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-10: German Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-11: French Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-12: French Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-13: Italian Sales for Advanced Wound Management Products, 2008–2016
Exhibit 4-14: Italian Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-15: UK Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-16: UK Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017

Exhibit 5-1: Coloplast Revenues by Business Area (DKK Millions)

Exhibit 5-2: Selected Johnson & Johnson Medical Devices and Diagnostics Companies

Exhibit 5-3: Leading Advanced Wound Management Products and Suppliers

Exhibit 5-4: Integra LifeSciences Financial Data, 2007, 2008 ($ Millions), Year Ending Dec. 31

Exhibit 5-5: Financial Data for Uluru, Fiscal Year 2007 and 2008

Exhibit 5-6: Oculus Innovative Sciences, FY Fourth Quarter 2008 vs. 2009 Data (Year-End March 31)

For more information kindly visit
http://www.bharatbook.com/Market-Research-Reports/Worldwide-Wound-Management-2008-2017-Established-and-Emerging-Products-Technologies-and-Markets-in-the-US-Europe-Japan-and-Rest-of-World.html

Worldwide Wound Management, 2008-2017: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World

This report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report details current clinical and technology developments in this huge worldwide market with high growth sectors, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

The report provides full year (actual) 2008 market size and share data, with forecast market data to 2017, for the U.S., Europe, Asia/Pacific and Rest of World.

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments — multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying the huge and evolving worldwide wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced wound care research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Table of Contents:

EXECUTIVE SUMMARY
Acute Wounds
Burns
Chronic Wounds
Products Used in Advanced Wound Management
Film Dressings
Hydrocolloid Dressings
Foam Dressings
Alginate Dressings
Hydrogels
Non-Adherent Dressings
Anti-Microbial Dressings
Wound Cleansers and Debriding Agents
Skin Replacements and Substitutes
Pharmacological Products
Physical Therapies
The Market
The Industry

SECTION 1: BACKGROUND
1.1 Industry Structure
1.2 A Complex Industry
1.3 Major Wound Management Corporations
1.4 Historical Perspective and Technology Breakthroughs
1.5 Worldwide Regulatory and Reimbursement Environment
1.5.1 Cost Effectiveness
1.5.2 Clinical
1.5.3 Regulatory
1.5.4 Reimbursement
1.5.4.1 U.S.A
1.5.4.2 European Union
1.5.4.3 France
1.5.4.4 Germany
1.5.4.5 United Kingdom .
1.5.4.6 Italy
1.5.4.7 Belgium
1.5.4.8 Spain
1.5.4.9 Scandinavia.
1.6 Geographical Differences in Treatments of Wounds
1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
1.8 Wound Management Trends
1.8.1 Surgical Wounds
1.8.2 Traumatic Wounds
1.8.3 Burns
1.8.4 Chronic Wounds
1.9 Market Dynamics

SECTION 2: CLINICAL BACKGROUND AND CASELOAD
2.1 Background
2.1.1 A Few Figures
2.1.2 Overview of Functions
2.1.3 Skin Anatomy: A Summary
2.2 Types of Wounds
2.2.1 Classification By Severity
2.2.2 Classification By Morphology
2.2.3 Classification By Etiology
2.2.4 Color Classification
2.3 Surgical Wounds
2.4 Traumatic Wounds
2.5 Burns
2.5.1 Debridement
2.5.2 Grafting
2.6 Pressure Ulcers
2.6.1 Ulcer Classification
2.6.2 Hospital-Acquired Ulcers
2.6.3 Management of Pressure Ulcers
2.7 Venous Ulcers
2.8 Arterial Ulcers
2.9 Diabetic Ulcers
2.9.1 Prevalence
2.9.2 Stages of Diabetic Ulcer
2.9.3 Treatment
2.9.3.1 Amputations
2.9.3.2 Abnormal Scarring
2.9.4 Acquired Immunodeficiency Syndrome
2.10 Wound Healing Physiology
2.10.1 Inflammatory Phase
2.10.2 Proliferative Phase
2.10.2.1 Angiogenesis
2.10.3 Maturation Phase
2.11 Factors Affecting Wound Healing
2.11.1 Extrinsic Factors
2.11.2 Mechanical Stress
2.11.3 Debris
2.11.4 Temperature
2.11.5 Desiccation and Maceration
2.11.6 Infection
2.11.7 Chemical Stress
2.11.8 Medication
2.11.9 Other Extrinsic Factors
2.11.10 Intrinsic Factors
2.11.11 Health Status
2.11.12 Age Factors
2.11.13 Body Build
2.11.14 Nutritional Status
2.12 Major Treatment Categories and Regimes
2.13 Incidence of Treatments, Growth Rates and Trends

SECTION 3: PRODUCTS, TECHNOLOGIES AND MARKETS
3.1 Background
3.2 Film Dressings
3.2.1 Overview
3.2.2 Product Examples
3.2.3 Market and Competitive Activity
3.3 Hydrocolloids
3.3.1 Overview
3.3.2 Product Examples
3.3.3 Market and Competitive Activity
3.4 Foam Dressings
3.4.1 Overview
3.4.2 Product Examples
3.4.3 Market and Competitive Activity
3.5 Alginate Dressings
3.5.1 Overview
3.5.2 Product Examples
3.5.3 Market and Competitive Activity
3.6 Hydrogels
3.6.1 Overview
3.6.2 Product Examples
3.6.3 Market and Competitive Activity
3.7 Non-Adherent Dressings
3.7.1 Overview
3.7.2 Product Examples
3.7.3 Market and Competitive Activity
3.8 Antimicrobial Dressings
3.8.1 Overview
3.8.2 Product Examples
3.8.3 Market and Competitive Activity
3.9 Tissue-Engineered Products
3.9.1 Overview
3.9.2 Traditional Skin Grafts
3.9.3 Skin Replacements
3.9.4 Product Examples
3.9.5 Market and Competitive Analysis
3.10 Pharmacological Products
3.10.1 Overview
3.10.2 Product Examples
3.10.2.1 Growth Factors
3.10.2.2 Growth Factors: Background.
3.10.2.3 Classification
3.10.2.4 Other Growth Factors
3.10.2.5 Non-Growth Factor Modulators
3.10.3 Market and Competitive Analysis
3.10.3.1 Growth Factors
3.10.3.2 Non-Growth Factor Stimulants
3.10.3.3 Gene Therapy
3.11 Physical Treatments
3.11.1 Negative Pressure Devices
3.11.2 Positive Pressure Devices
3.11.3 Mechanically Assisted Wound Closure
3.11.4 Other Physical Wound Therapies
3.11.4.1 Hydrotherapy
3.11.4.2 Electrical Stimulation
3.11.4.3 Electromagnetic Stimulation Devices
3.11.4.4 Ultraviolet Therapy
3.11.4.5 Hyperbaric Oxygen Therapy
3.11.4.6 Ultrasound Devices
3.11.4.7 Laser Devices
3.11.4.8 Wound Imaging/Documentation
3.11.5 Market and Competitive Analysis..
3.11.5.1 Pressure Relief Devices.
3.11.5.2 Hydrotherapy
3.11.5.3 Electrical Stimulation
3.11.5.4 Hyperbaric Oxygen Therapy

SECTION 4: COUNTRY MARKET ANALYSIS
4.1 Global Overview
4.2 Market Estimates
4.2.1 Market Potential
4.2.2 Leading Wound Care Companies
4.2.3 Leading National Markets
4.3 United States
4.3.1 Market Opportunity.
4.3.2 Market for Advanced Wound Management Products
4.4 Japan
4.4.1 Wound Care Market
4.4.2 Market Opportunity
4.4.3 Leading Companies
4.5 Germany
4.5.1 Wound Care Market
4.5.2 Leading Companies.
4.6 France
4.6.1 Wound Care Market
4.6.2 Leading Companies.
4.7 Italy
4.7.1 Wound Care Market
4.7.2 Leading Companies.
4.8 United Kingdom
4.8.1 Wound Care Market
4.8.2 Leading Companies

SECTION 5: COMPANY PROFILES
5.1 Major Companies
5.1.1 3M Health Care
5.1.2 B. Braun Melsungen AG
5.1.3 Coloplast Group
5.1.3.1 Financials
5.1.4 ConvaTec Inc.
5.1.5 Covidien
5.1.5.1 Kendall
5.1.6 Derma Sciences, Inc.
5.1.7 DeRoyal Industries Inc.
5.1.8 Ethicon (Johnson & Johnson)
5.1.9 Gentell Inc.
5.110 Geritrex Corp
5.1.11 Hartmann Group
5.1.12 Hollister Incorporated
5.1.13 Lohmann & Rauscher International GmbH and Co. KG
5.1.14 Medline Industries
5.1.15 Mölnlycke Health Care AB
5.1.16 Smith & Nephew plc
5.1.17 Systagenix Wound Management (US), Inc.
5.1.18 UDL Laboratories
5.2 Specialist Companies
5.2.1 Antimicrobial Dressings
5.2.1.1 AcryMed Inc.
5.2.1.2 Argentum Products LLC
5.2.1.3 Microban International Ltd
5.2.2 Oxygen Therapy
5.2.2.1 Perry Baromedical
5.2.3 Tissue Regeneration
5.2.3.1 Perry Baromedical
5.2.3.2 Celltran Limited
5.2.3.3 Euroderm AG
5.2.3.4 Fidia Advanced Biopolymers
5.2.3.5 Forticell Bioscience, Inc.
5.2.3.6 Genzyme Biosurgery
5.2.3.7 Integra LifeSciences Inc.
5.2.3.8 Organogenesis Inc.
5.2.3.9 Kinetic Concepts Inc.
5.2.3.9.1 LifeCell Corporation
5.2.4 Growth Factors
5.2.4.1 ES Cell International
5.2.5 Electrical Therapies
5.2.5.1 BioMedical Life Systems, Inc.
5.2.5.2 Diapulse Corporation of America
5.2.5.3 Electromedical Products International Inc.
5.2.5.4 Koldcare
5.2.5.5 Microvas Technologies
5.2.6 Odor Control
5.2.6.1 CliniMed
5.2.7 Other Therapeutic Modalities
5.2.7.1 AGT Sciences Ltd
5.2.7.2 Agennix
5.2.7.3 Advanced Medical Solutions Group plc
5.2.7.4 Anodyne Therapy LLC
5.2.7.5 Applied Tissue Technologies
5.2.7.6 Regenesis Biomedical Inc.
5.2.7.7 Roho Inc.
5.2.7.8 Uluru, Inc.
5.2.8 Summary Profiles
5.2.8.1 AciesHealth
5.2.8.2 Bard Medical Division
5.2.8.3 Brennen Medical Inc.
5.2.8.4 BSN medical Ltd
5.2.8.5 Celleration, Inc.
5.2.8.6 DermaRite Industries LLC
5.2.8.7 Ferris Manufacturing Corp.
5.2.8.8 Fibrogen
5.2.8.9 Geistlich Pharma.
5.2.8.10 Healthpoint
5.2.8.11 HemCon Medical Technologies
5.2.8.12 Human BioSciences, Inc.
5.2.8.13 Hymed Group Corporation
5.2.8.14 Innocol, Inc.
5.2.8.15 Laboratoires Urgo
5.2.8.16 LifeWave Ltd
5.2.8.17 Longport Inc.
5.2.8.18 MPM Medical
5.2.8.19 Nagor Ltd
5.2.8.20 Oculus Innovative Sciences, Inc.
5.2.8.21 Pioneer Surgical Technology, Inc.
5.2.8.22 Unomedical
5.2.8.23 Swiss American Products, Inc.
5.2.8.23.1 Wound Care Products
5.2.8.24 Wound Care Innovations, LLC
APPENDIX: LIST OF COMPANIES

List of Exhibits

Exhibit ES-1: Advanced Wound Care Market, by Segment, 2008 & 2017
Exihbit ES-2: Advanced Wound Care Market Shares by Competitor, 2008

Exhibit 1-1: Worldwide Wound Prevalence by Etiology, 2008
Exhibit 1-2: Advanced Wound Management, Worldwide Market Forecast, 2008–2017
Exhibit 1-3: Total World Wound Management Products, Market Forecast, 2008–2017

Exhibit 2-1: Classification of Wounds by Etiology
Exhibit 2-2: Old and New Classification Systems for Burns
Exhibit 2-3: Distribution of Pressure Ulcers

Exhibit 3-1: Companies and Products in the Film Dressings Category
Exhibit 3-2: Film Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-3: Film Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-4: Companies and Products in the Hydrocolloid Dressings Category
Exhibit 3-5: Hydrocolloid Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-6: Hydrocolloid Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-7: Leading Companies and Products in the Foam Dressings Category
Exhibit 3-8: Foam Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-9: Foam Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-10: Companies and Products in the Alginate Dressings Category
Exhibit 3-11: Alginate Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-12: Alginate Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-13: Amorphous Hydrogels – Companies and Products
Exhibit 3-14: Impregnated Hydrogels – Companies and Products
Exhibit 3-15: Sheet Hydrogels, Companies and Products
Exhibit 3-16: Hydrogel Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-17: Hydrogel Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-18: Companies and Products in the Non-Adherent Dressings Category
Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-21: Companies and Products in the Antimicrobial Dressings Category
Exhibit 3-22: Antimicrobial Dressings, Worldwide Market Forecast, 2008-2017
Exhibit 3-23: Antimicrobial Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-24: Companies and Products in the Tissue Engineering Category
Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2008–2017
Exhibit 3-26: Tissue Engineering, Worldwide Share by Supplier, 2007, 2008
Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2008–2017
Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category
Exhibit 3-29: Physical Wound Therapies, Worldwide Market Forecast, 2008–2017

Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2008–2017
Exhibit 4-2: Leading Global Wound Care Companies by Market Share
Exhibit 4-3: Leading Global Wound Care Companies, Market Share, 2008
Exhibit 4-4: National Shares of the Global Advanced Wound Management Market, 2008
Exhibit 4-5: Forecast U.S. Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-6: Forecast U.S. Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-7: Japanese Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-8: Japanese Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-9: German Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-10: German Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-11: French Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-12: French Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-13: Italian Sales for Advanced Wound Management Products, 2008–2016
Exhibit 4-14: Italian Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-15: UK Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-16: UK Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017

Exhibit 5-1: Coloplast Revenues by Business Area (DKK Millions)

Exhibit 5-2: Selected Johnson & Johnson Medical Devices and Diagnostics Companies

Exhibit 5-3: Leading Advanced Wound Management Products and Suppliers

Exhibit 5-4: Integra LifeSciences Financial Data, 2007, 2008 ($ Millions), Year Ending Dec. 31

Exhibit 5-5: Financial Data for Uluru, Fiscal Year 2007 and 2008

Exhibit 5-6: Oculus Innovative Sciences, FY Fourth Quarter 2008 vs. 2009 Data (Year-End March 31)

For more please visit
http://www.bharatbook.com/Market-Research-Reports/Worldwide-Wound-Management-2008-2017-Established-and-Emerging-Products-Technologies-and-Markets-in-the-US-Europe-Japan-and-Rest-of-World.html

United States Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the United States wound care management market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management market in United States

Scope

- The report provides wound care management information broken down into detailed categories and segments in United States.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the wound care management market in United States.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents :

1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 15
2 Introduction 17
2.1 What Is This Report About? 17
3 Definitions of Markets Covered in This Report 18
3.1 Wound Care Management 18
3.2 Advanced Wound Management 18
3.2.1 Alginates 18
3.2.2 Collagens 18
3.2.3 Foams 18
3.2.4 Hydrocolloids 18
3.2.5 Hydrofibres 18
3.2.6 Hydrogels 18
3.2.7 Negative Pressure Wound Therapy (NPWT) 18
3.2.8 Semi-Permeable Films 18
3.3 Compression Therapy 18
3.4 Ostomy 19
3.5 Traditional Wound Management 19
3.6 Wound Closure Devices 19
3.6.1 Skin Closure Devices 19
3.6.2 Tissue Sealants 19
4 Healthcare Sector Review 20
4.1 Healthcare Expenditure 20
4.2 Healthcare Infrastructure 25
4.2.1 Healthcare Personnel Data 27
4.2.2 Healthcare Facilities Data 30
4.3 United States Healthcare Trade Statistics 32
5 Regulation System 33
5.1 Regulation System 33
5.2 Medical Equipment Approval Process 33
5.2.1 Pre-market Approval Process 34
5.2.2 Intended use and Indications for use 34
5.2.3 Predicate Device 35
5.2.4 Safe and Effective 35
5.2.5 Other Category Devices 37
5.2.6 Post-Market Approval Process 38
5.2.7 Compliance and Enforcement 38
5.2.8 Registration Fee 39
5.2.9 Approval Time 39
6 Pricing and Reimbursement 40
6.1 Government Policies 40
6.2 Private Insurance 41
6.3 Diagnosis Related Groups (DRG) 42
7 Distribution Structure 43
7.1 Distribution Structure 43
8 Wound Care Management In United States 44
8.1 Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015 44
8.2 Wound Care Management, United States, Overall Revenue ($ mn), 2000-2015 45
8.3 Wound Care Management, United States, Category Volume (Units), 2000-2015 49
8.4 Wound Care Management, United States, Company Share (2006-2007) 54
9 Advanced Wound Management In United States 55
9.1 Advanced Wound Management Overall Revenue (2000-2015) 55
9.2 Advanced Wound Management Overall Volume (2000-2015) 59
9.3 Advanced Wound Management Average Price (2000-2015) 63
9.4 Advanced Wound Management Distribution Share (2007-2008) 65
9.5 Advanced Wound Management, United States, Company Share (2006-2007) 66
10 Compression Therapy In United States 67
10.1 Compression Therapy Overall Revenue (2000-2015) 67
10.2 Compression Therapy Overall Volume (2000-2015) 69
10.3 Compression Therapy Average Price (2000-2015) 71
10.4 Compression Therapy Distribution Share (2007-2008) 72
10.5 Compression Therapy, United States, Company Share (2006-2007) 73
11 Ostomy In United States 74
11.1 Ostomy Overall Revenue (2000-2015) 74
11.2 Ostomy Overall Volume (2000-2015) 76
11.3 Ostomy Average Price (2000-2015) 78
11.4 Ostomy Distribution Share (2007-2008) 79
11.5 Ostomy, United States, Company Share (2006-2007) 80
12 Traditional Wound Management In United States 81
12.1 Traditional Wound Management Overall Revenue (2000-2015) 81
12.2 Traditional Wound Management Overall Volume (2000-2015) 83
12.3 Traditional Wound Management Average Price (2000-2015) 85
12.4 Traditional Wound Management Distribution Share (2007-2008) 86
12.5 Traditional Wound Management, United States, Company Share (2006-2007) 87
13 Wound Closure Devices In United States 88
13.1 Wound Closure Devices Overall Revenue (2000-2015) 88
13.2 Wound Closure Devices Overall Volume (2000-2015) 90
13.3 Wound Closure Devices Average Price (2000-2015) 92
13.4 Wound Closure Devices Distribution Share (2007-2008) 93
13.5 Wound Closure Devices, United States, Company Share (2006-2007) 94
14 Overview of Key Companies in United States Wound Care Management Market 95
14.1 Baxter International Inc. 95
14.1.1 Company Overview 95
14.1.2 Value Chain Analysis 96
14.1.2.1 Manufacturing 96
14.1.2.2 Product Development 96
14.1.2.3 Sales and Marketing 97
14.2 Covidien Ltd. 99
14.2.1 Company Overview 99
14.2.2 Value Chain Analysis 100
14.2.2.1 Manufacturing 100
14.2.2.2 Product Development 100
14.2.2.3 Sales and Marketing 101
14.3 3M Company 103
14.3.1 Company Overview 103
14.4 Ethicon, Inc. 104
14.4.1 Company Overview 104
14.4.2 Ethicon, Inc. Pipeline Products 104
14.4.2.1 Ethicon, Inc. Pipeline Products By Equipment Type 104
14.4.2.2 Ethicon, Inc. Pipeline Products By Development Stage 104
14.4.2.3 Ethicon, Inc. Pipeline Products By Therapy Area 105
14.4.2.4 Ethicon, Inc. Pipeline Products By Clinical Trials 105
14.5 Smith & Nephew Plc 106
14.5.1 Company Overview 106
14.5.2 Value Chain Analysis 107
14.5.2.1 Manufacturing 107
14.5.2.2 Product Development 108
14.5.2.3 Sales and Marketing 108
14.5.3 Smith & Nephew Plc Pipeline Products 109
14.5.3.1 Smith & Nephew Plc Pipeline Products By Equipment Type 109
14.5.3.2 Smith & Nephew Plc Pipeline Products By Development Stage 110
14.5.3.3 Smith & Nephew Plc Pipeline Products By Therapy Area 110
14.5.3.4 Smith & Nephew Plc Pipeline Products By News Summary 111
14.6 ConvaTec 112
14.6.1 Company Overview 112
14.7 Johnson & Johnson 113
14.7.1 Company Overview 113
14.7.2 Value Chain Analysis 113
14.7.2.1 Manufacturing 114
14.7.2.2 Product Development 114
14.7.2.3 Sales and Marketing 115
14.8 Coloplast A/S 116
14.8.1 Company Overview 116
14.8.2 Value Chain Analysis 116
14.8.2.1 Manufacturing 117
14.8.2.2 Product Development 117
14.8.2.3 Sales and Marketing 118
14.9 Kinetic Concepts, Inc. 119
14.9.1 Company Overview 119
14.9.2 Value Chain Analysis 120
14.9.2.1 Manufacturing 120
14.9.2.2 Product Development 121
14.9.2.3 Sales and Marketing 122
14.9.3 Kinetic Concepts, Inc. Pipeline Products 123
14.9.3.1 Kinetic Concepts, Inc. Pipeline Products By Equipment Type 123
14.9.3.2 Kinetic Concepts, Inc. Pipeline Products By Development Stage 123
14.9.3.3 Kinetic Concepts, Inc. Pipeline Products By Therapy Area 123
14.9.3.4 Kinetic Concepts, Inc. Pipeline Products By Clinical Trials 123
14.9.3.5 Kinetic Concepts, Inc. Pipeline Products By News Summary 124
14.10 Advanced Medical Solutions Group plc 125
14.10.1 Company Overview 125
14.10.2 Value Chain Analysis 126
14.10.2.1 Manufacturing 126
14.10.2.2 Product Development 126
14.10.2.3 Sales and Marketing 127
14.10.3 Advanced Medical Solutions Group Plc Pipeline Products 128
14.10.3.1 Advanced Medical Solutions Group Plc Pipeline Products By Equipment Type 128
14.10.3.2 Advanced Medical Solutions Group Plc Pipeline Products By Development Stage 128
14.10.3.3 Advanced Medical Solutions Group Plc Pipeline Products By Therapy Area 128
14.11 HARTMANN GROUP 129
14.11.1 Company Overview 129
14.11.2 Value Chain Analysis 129
14.11.2.1 Manufacturing 130
14.11.2.2 Product Development 130
14.11.2.3 Sales and Marketing 130
14.12 BSN medical GmbH 131
14.12.1 Company Overview 131
14.13 Hollister Incorporated 131
14.13.1 Company Overview 131
14.14 Julius Zorn, Inc. 131
14.14.1 Company Overview 131
14.15 SIGVARIS, Inc. 131
14.15.1 Company Overview 131
14.16 AMD-Ritmed Inc. 132
14.16.1 Company Overview 132
14.17 Integra LifeSciences Holdings Corporation 133
14.17.1 Company Overview 133
14.17.2 Value Chain Analysis 133
14.17.2.1 Manufacturing 134
14.17.2.2 Product Development 134
14.17.2.3 Sales and Marketing 135
14.18 Derma Sciences, Inc. 136
14.18.1 Company Overview 136
14.18.2 Derma Sciences, Inc. Pipeline Products 136
14.18.2.1 Derma Sciences, Inc. Pipeline Products By Equipment Type 136
14.18.2.2 Derma Sciences, Inc. Pipeline Products By Development Stage 136
14.18.2.3 Derma Sciences, Inc. Pipeline Products By Therapy Area 136
14.18.2.4 Derma Sciences, Inc. Pipeline Products By News Summary 137
14.19 Lifecore Biomedical, Inc. 138
14.19.1 Company Overview 138
14.19.2 Lifecore Biomedical, Inc. Pipeline Products 138
14.19.2.1 Lifecore Biomedical, Inc. Pipeline Products By Equipment Type 138
14.19.2.2 Lifecore Biomedical, Inc. Pipeline Products By Development Stage 138
14.19.2.3 Lifecore Biomedical, Inc. Pipeline Products By Therapy Area 139
14.19.2.4 Lifecore Biomedical, Inc. Pipeline Products By News Summary 139
14.20 Covalent Medical, Inc. 140
14.20.1 Company Overview 140
14.20.2 Covalent Medical, Inc. Pipeline Products 140
14.20.2.1 Covalent Medical, Inc. Pipeline Products by Equipment Type 140
14.20.2.2 Covalent Medical, Inc. Pipeline Products By Development Stage 140
14.20.2.3 Covalent Medical, Inc. Pipeline Products By Therapy Area 140
14.21 FzioMed, Inc. 141
14.21.1 Company Overview 141
14.21.2 FzioMed, Inc. Pipeline Products 141
14.21.2.1 FzioMed, Inc. Pipeline Products By Equipment Type 141
14.21.2.2 FzioMed, Inc. Pipeline Products By Development Stage 141
14.21.2.3 FzioMed, Inc. Pipeline Products By Therapy Area 141
14.21.2.4 FzioMed, Inc. Pipeline Products By Clinical Trials 142
14.21.2.5 FzioMed, Inc. Pipeline Products By News Summary 142
14.22 IYIA Technologies, Inc. 143
14.22.1 Company Overview 143
14.22.2 IYIA Technologies, Inc. Pipeline Products 143
14.22.2.1 IYIA Technologies, Inc. Pipeline Products By Equipment Type 143
14.22.2.2 IYIA Technologies, Inc. Pipeline Products By Development Stage 143
14.22.2.3 IYIA Technologies, Inc. Pipeline Products By Therapy Area 143
14.22.2.4 IYIA Technologies, Inc. Pipeline Products By Clinical Trials 144
14.22.2.5 IYIA Technologies, Inc. Pipeline Products By News Summary 144
14.23 ThermoGenesis Corp. 145
14.23.1 Company Overview 145
14.23.2 ThermoGenesis Corp. Pipeline Products 145
14.23.2.1 ThermoGenesis Corp. Pipeline Products By Equipment Type 145
14.23.2.2 ThermoGenesis Corp. Pipeline Products By Development Stage 145
14.23.2.3 ThermoGenesis Corp. Pipeline Products By Therapy Area 146
14.23.2.4 ThermoGenesis Corp. Pipeline Products By Clinical Trials 146
14.23.2.5 ThermoGenesis Corp. Pipeline Products By News Summary 146
14.24 CSMG Technologies, Inc. 147
14.24.1 Company Overview 147
14.24.2 CSMG Technologies, Inc. Pipeline Products 147
14.24.2.1 CSMG Technologies, Inc. Pipeline Products By Equipment Type 147
14.24.2.2 CSMG Technologies, Inc. Pipeline Products By Development Stage 147
14.24.2.3 CSMG Technologies, Inc. Pipeline Products By Therapy Area 147
14.25 Molnlycke Health Care AB 148
14.25.1 Company Overview 148
14.26 DeRoyal Industries, Inc. 148
14.26.1 Company Overview 148
14.27 Tyco Healthcare/Kendall 148
14.27.1 Company Overview 148
14.28 Southwest Technologies, Inc. 149
14.28.1 Company Overview 149
14.29 TEI Biosciences Inc. 149
14.29.1 Company Overview 149
14.30 Neuro Resource Group, Inc. 149
14.30.1 Company Overview 149
15 Financial Deals Landscape 150
15.1 Acquisition 150
15.1.1 Applied Nanoscience Terminates Acquisition Of Emergency Filtration Products 150
15.1.2 Moog Acquires Ethox International 151
15.1.3 Johnson & Johnson Acquires Omrix Biopharmaceuticals 152
15.1.4 Filtrona Acquires Lendell Manufacturing 154
15.2 Partnerships 155
15.2.1 ACell Signs An Agreement With Medline Industries 155
15.2.2 HyperBranch Medical Technology Enters Into An Agreement With BD 156
15.2.3 Ivivi Technologies Signs An Agreement With Recovercare 157
15.2.4 ConvaTec Enters Into An Agreement With Boehringer Wound Systems 158
16 Recent Developments 159
16.1 Strategy and Business Planning 159
16.1.1 Mar 30, 2009: KCI Announces Cost Reduction Initiatives 159
16.1.2 Feb 02, 2009: ConvaTec Plans To Expand In Greensboro 159
16.1.3 Oct 21, 2008: Smith & Nephew to Open New Biologics & Spine Business Unit 159
16.1.4 Oct 16, 2008: Pegasus Biologics Announces Facility Expansion 160
16.2 Legal and Regulatory 160
16.2.1 Feb 02, 2009: KCI Says Court Again Affirms Patents as Valid 160
16.2.2 Dec 18, 2008: KCI Files Patent Violation Lawsuit Against Convatec and Boehringer 160
16.2.3 Dec 11, 2008: KCI Files New Patent Lawsuit against Smith & Nephew 161
16.3 Government and Public Interest 161
16.3.1 Mar 23, 2009: CMS Considers HHS Recommendations on Payments for NPWT Pumps 161
16.4 Product Approvals 161
16.4.1 Feb 26, 2009: Quick-Med Technologies Receives FDA Clearance For NIMBUS 161
16.4.2 Jan 07, 2009: Adhezion Biomedical Announces 510(K) Clearance For SurgiSeal 162
16.4.3 Nov 25, 2008: KCI’s LifeCell Granted CE Mark For Its Strattice Reconstructive Tissue Matrix 162
16.4.4 Nov 13, 2008: Wound Management Technologies Announces FDA 510k Clearance Of Collagen Technology 163
16.4.5 Oct 14, 2008: KCI Receives FDA Clearance For Its LifeCell Tissue Matrix For The Management Of Wounds Utilizing Proprietary Strattice Technology 163
17 Appendix 164
17.1 Global Markets Direct Research Methodology 164
17.2 Coverage 165
17.3 Secondary Research 165
17.4 Primary Research 166
17.5 Models 166
17.6 Forecasts 167
17.7 Expert Panel Validation 167
17.8 Currency Conversion 168
17.9 Contact Us 169
17.10 Disclaimer 169

1.1 List of Tables
Table 1: United States Healthcare Expenditure, 2003-2010 21
Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003 22
Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003 22
Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003 22
Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004 23
Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004 24
Table 7: Total Number of Doctors in the United States, 2003-2010 27
Table 8: Number of Doctors by Specialty in the United States, 2003-2010 28
Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 29
Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.) 30
Table 11: Total Hospitals in the United States, 2000-2004 30
Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004 31
Table 13: Number of Hospital Beds in the United States, 2000-2004 31
Table 14: Number of Hospital Beds by Range in the United States, 2000-2004 31
Table 15: United States Healthcare Trade Statistics, 2001-2006 32
Table 16: Medical Equipment Registration Fee in United States, 2007 39
Table 17: Medical Device Approval Time in United States, 2004 39
Table 18: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015 44
Table 19: Wound Care Management, United States, Overall Revenue ($ mn), 2000-2015 45
Table 20: Wound Care Management, United States, Cross-Category Analysis, 2000-2015 46
Table 21: Wound Care Management, United States, Overall Revenue ($ mn), Historic, 2000-2008 47
Table 22: Wound Care Management, United States, Overall Revenue ($ mn), Forecast, 2008-2015 48
Table 23: Wound Care Management, United States, Category Volume (Units), 2000-2015 49
Table 24: Wound Care Management, United States, Category Volume (Units), Historic, 2000-2008 51
Table 25: Wound Care Management, United States, Category Volume (Units), Forecast, 2008-2015 53
Table 26: Wound Care Management, United States, Company Share by Revenue ($ mn), 2006-2007 54
Table 27: Advanced Wound Management, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 56
Table 28: Advanced Wound Management, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 58
Table 29: Advanced Wound Management, United States, Volume (Units) by Segment, Historic, 2000-2008 60
Table 30: Advanced Wound Management, United States, Volume (Units) by Segment, Forecast, 2008-2015 62
Table 31: Advanced Wound Management, United States, Average Price ($), Historic, 2000-2008 63
Table 32: Advanced Wound Management, United States, Average Price ($), Forecast, 2008-2015 64
Table 33: Advanced Wound Management, United States, Distribution Share by Revenue ($mn), 2007-2008 65
Table 34: Advanced Wound Management, United States, Company Share by Revenue ($ mn), 2006-2007 66
Table 35: Compression Therapy, United States, Revenue ($ mn), Historic, 2000-2008 67
Table 36: Compression Therapy, United States, Revenue ($ mn), Forecast, 2008-2015 68
Table 37: Compression Therapy, United States, Volume (Units), Historic, 2000-2008 69
Table 38: Compression Therapy, United States, Volume (Units), Forecast, 2008-2015 70
Table 39: Compression Therapy, United States, Average Price ($), Historic, 2000-2008 71
Table 40: Compression Therapy, United States, Average Price ($), Forecast, 2008-2015 71
Table 41: Compression Therapy, United States, Distribution Share by Revenue ($mn), 2007-2008 72
Table 42: Compression Therapy, United States, Company Share by Revenue ($ mn), 2006-2007 73
Table 43: Ostomy, United States, Revenue ($ mn), Historic, 2000-2008 74
Table 44: Ostomy, United States, Revenue ($ mn), Forecast, 2008-2015 75
Table 45: Ostomy, United States, Volume (Units), Historic, 2000-2008 76
Table 46: Ostomy, United States, Volume (Units), Forecast, 2008-2015 77
Table 47: Ostomy, United States, Average Price ($), Historic, 2000-2008 78
Table 48: Ostomy, United States, Average Price ($), Forecast, 2008-2015 78
Table 49: Ostomy, United States, Distribution Share by Revenue ($mn), 2007-2008 79
Table 50: Ostomy, United States, Company Share by Revenue ($ mn), 2006-2007 80
Table 51: Traditional Wound Management, United States, Revenue ($ mn), Historic, 2000-2008 81
Table 52: Traditional Wound Management, United States, Revenue ($ mn), Forecast, 2008-2015 82
Table 53: Traditional Wound Management, United States, Volume (Units), Historic, 2000-2008 83
Table 54: Traditional Wound Management, United States, Volume (Units), Forecast, 2008-2015 84
Table 55: Traditional Wound Management, United States, Average Price ($), Historic, 2000-2008 85
Table 56: Traditional Wound Management, United States, Average Price ($), Forecast, 2008-2015 85
Table 57: Traditional Wound Management, United States, Distribution Share by Revenue ($mn), 2007-2008 86
Table 58: Traditional Wound Management, United States, Company Share by Revenue ($ mn), 2006-2007 87
Table 59: Wound Closure Devices, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 88
Table 60: Wound Closure Devices, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 89
Table 61: Wound Closure Devices, United States, Volume (Units) by Segment, Historic, 2000-2008 90
Table 62: Wound Closure Devices, United States, Volume (Units) by Segment, Forecast, 2008-2015 91
Table 63: Wound Closure Devices, United States, Average Price ($), Historic, 2000-2008 92
Table 64: Wound Closure Devices, United States, Average Price ($), Forecast, 2008-2015 92
Table 65: Wound Closure Devices, United States, Distribution Share by Revenue ($mn), 2007-2008 93
Table 66: Wound Closure Devices, United States, Company Share by Revenue ($ mn), 2006-2007 94
Table 67: Ethicon, Inc. Pipeline Products by Equipment Type 104
Table 68: Ethicon, Inc. Pipeline Products By Development Stage 104
Table 69: Ethicon, Inc. Pipeline Products By Therapy Area 105
Table 70: Ethicon, Inc. Pipeline Products By Clinical Trials 105
Table 71: Smith & Nephew Plc Pipeline Products by Equipment Type 109
Table 72: Smith & Nephew Plc Pipeline Products By Development Stage 110
Table 73: Smith & Nephew Plc Pipeline Products By Therapy Area 110
Table 74: Smith & Nephew Plc Pipeline Products By News Summary 111
Table 75: Kinetic Concepts, Inc. Pipeline Products by Equipment Type 123
Table 76: Kinetic Concepts, Inc. Pipeline Products By Development Stage 123
Table 77: Kinetic Concepts, Inc. Pipeline Products By Therapy Area 123
Table 78: Kinetic Concepts, Inc. Pipeline Products By Clinical Trials 123
Table 79: Kinetic Concepts, Inc. Pipeline Products By News Summary 124
Table 80: Advanced Medical Solutions Group Plc Pipeline Products by Equipment Type 128
Table 81: Advanced Medical Solutions Group Plc Pipeline Products By Development Stage 128
Table 82: Advanced Medical Solutions Group Plc Pipeline Products By Therapy Area 128
Table 83: Derma Sciences, Inc. Pipeline Products by Equipment Type 136
Table 84: Derma Sciences, Inc. Pipeline Products By Development Stage 136
Table 85: Derma Sciences, Inc. Pipeline Products By Therapy Area 136
Table 86: Derma Sciences, Inc. Pipeline Products By News Summary 137
Table 87: Lifecore Biomedical, Inc. Pipeline Products by Equipment Type 138
Table 88: Lifecore Biomedical, Inc. Pipeline Products By Development Stage 138
Table 89: Lifecore Biomedical, Inc. Pipeline Products By Therapy Area 139
Table 90: Lifecore Biomedical, Inc. Pipeline Products By News Summary 139
Table 91: Covalent Medical, Inc. Pipeline Products by Equipment Type 140
Table 92: Covalent Medical, Inc. Pipeline Products By Development Stage 140
Table 93: Covalent Medical, Inc. Pipeline Products By Therapy Area 140
Table 94: FzioMed, Inc. Pipeline Products by Equipment Type 141
Table 95: FzioMed, Inc. Pipeline Products By Development Stage 141
Table 96: FzioMed, Inc. Pipeline Products By Therapy Area 141
Table 97: FzioMed, Inc. Pipeline Products By Clinical Trials 142
Table 98: FzioMed, Inc. Pipelinee Products By News Summary 142
Table 99: IYIA Technologies, Inc. Pipeline Products by Equipment Type 143
Table 100: IYIA Technologies, Inc. Pipeline Products By Development Stage 143
Table 101: IYIA Technologies, Inc. Pipeline Products By Therapy Area 143
Table 102: IYIA Technologies, Inc. Pipeline Products By Clinical Trials 144
Table 103: IYIA Technologies, Inc. Pipeline Products By News Summary 144
Table 104: ThermoGenesis Corp. Pipeline Products by Equipment Type 145
Table 105: ThermoGenesis Corp. Pipeline Products By Development Stage 145
Table 106: ThermoGenesis Corp. Pipeline Products By Therapy Area 146
Table 107: ThermoGenesis Corp. Pipeline Products By Clinical Trials 146
Table 108: ThermoGenesis Corp. Pipeline Products By News Summary 146
Table 109: CSMG Technologies, Inc. Pipeline Products by Equipment Type 147
Table 110: CSMG Technologies, Inc. Pipeline Products By Development Stage 147
Table 111: CSMG Technologies, Inc. Pipeline Products By Therapy Area 147
Table 112: Applied Nanoscience Terminates Acquisition Of Emergency Filtration Products 150
Table 113: Moog Acquires Ethox International 151
Table 114: Johnson & Johnson Acquires Omrix Biopharmaceuticals 152
Table 115: Filtrona Acquires Lendell Manufacturing 154
Table 116: ACell Signs An Agreement With Medline Industries 155
Table 117: HyperBranch Medical Technology Enters Into An Agreement With BD 156
Table 118: Ivivi Technologies Signs An Agreement With Recovercare 157
Table 119: ConvaTec Enters Into An Agreement With Boehringer Wound Systems 158
Table 120: USD to Local Currency, Average Exchange Rate 2008 168

1.2 List of Figures
Figure 1: United States, Healthcare Expenditure by Source, 2003 21
Figure 2: United States, Healthcare Infrastructure, Top Level View, 2007 26
Figure 3: Healthcare Expenses Segmentation by End User, 2003 27
Figure 4: Medical Equipment Approval Process in the United States, 2007 34
Figure 5: PMA Approval Process in the United States, 2007 36
Figure 6: The 510(k) Approval Process for Medical Devices in the United States, 2007 37
Figure 7: Reimbursement Structure in the United States, 2007 42
Figure 8: Distribution Structure of Medical Equipment in the United States, 2006 43
Figure 9: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015 44
Figure 10: Wound Care Management, United States, Overall Revenue ($ mn), 2000-2015 45
Figure 11: Wound Care Management, United States, Cross-Category Analysis, 2000-2015 46
Figure 12: Wound Care Management, United States, Overall Revenue ($ mn), Historic, 2000-2008 47
Figure 13: Wound Care Management, United States, Overall Revenue ($ mn), Forecast, 2008-2015 48
Figure 14: Wound Care Management, United States, Category Volume (Units), 2000-2015 49
Figure 15: Wound Care Management, United States, Category Volume (Units), Historic, 2000-2008 50
Figure 16: Wound Care Management, United States, Category Volume (Units), Forecast, 2008-2015 52
Figure 17: Wound Care Management, United States, Company Share (%), 2007 54
Figure 18: Advanced Wound Management, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 55
Figure 19: Advanced Wound Management, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 57
Figure 20: Advanced Wound Management, United States, Volume (Units) by Segment, Historic, 2000-2008 59
Figure 21: Advanced Wound Management, United States, Volume (Units) by Segment, Forecast, 2008-2015 61
Figure 22: Advanced Wound Management, United States, Company Share (%), 2007 66
Figure 23: Compression Therapy, United States, Revenue ($ mn), Historic, 2000-2008 67
Figure 24: Compression Therapy, United States, Revenue ($ mn), Forecast, 2008-2015 68
Figure 25: Compression Therapy, United States, Volume (Units), Historic, 2000-2008 69
Figure 26: Compression Therapy, United States, Volume (Units), Forecast, 2008-2015 70
Figure 27: Compression Therapy, United States, Company Share (%), 2007 73
Figure 28: Ostomy, United States, Revenue ($ mn), Historic, 2000-2008 74
Figure 29: Ostomy, United States, Revenue ($ mn), Forecast, 2008-2015 75
Figure 30: Ostomy, United States, Volume (Units), Historic, 2000-2008 76
Figure 31: Ostomy, United States, Volume (Units), Forecast, 2008-2015 77
Figure 32: Ostomy, United States, Company Share (%), 2007 80
Figure 33: Traditional Wound Management, United States, Revenue ($ mn), Historic, 2000-2008 81
Figure 34: Traditional Wound Management, United States, Revenue ($ mn), Forecast, 2008-2015 82
Figure 35: Traditional Wound Management, United States, Volume (Units), Historic, 2000-2008 83
Figure 36: Traditional Wound Management, United States, Volume (Units), Forecast, 2008-2015 84
Figure 37: Traditional Wound Management, United States, Company Share (%), 2007 87
Figure 38: Wound Closure Devices, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 88
Figure 39: Wound Closure Devices, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 89
Figure 40: Wound Closure Devices, United States, Volume (Units) by Segment, Historic, 2000-2008 90
Figure 41: Wound Closure Devices, United States, Volume (Units) by Segment, Forecast, 2008-2015 91
Figure 42: Wound Closure Devices, United States, Company Share (%), 2007 94
Figure 43: Baxter International Inc. Value Chain Analysis 96
Figure 44: Covidien Ltd./Tyco Healthcare Value Chain Analysis 100
Figure 45: Smith & Nephew Plc Value Chain Analysis 107
Figure 46: Johnson & Johnson Value Chain Analysis 113
Figure 47: Coloplast A/S Value Chain Analysis 116
Figure 48: Kinetic Concepts, Inc. Value Chain Analysis 120
Figure 49: Advanced Medical Solutions Group Plc Value Chain Analysis 126
Figure 50: Hartmann Group Value Chain Analysis 129
Figure 51: Integra LifeSciences Holdings Corporation Value Chain Analysis 133
Figure 52: Global Markets Direct Methodology 164

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/United-States-Wound-Care-Management-Investment-Opportunities-Analysis-and-Forecasts.html

Or

Contact us at:
Bharat Book Bureau
Tel: +91 22 2757 8668
Fax: +91 22 2757 9131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com

Asia Pacific Wound Care Management Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to Asia Pacific wound care management market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in Asia Pacific

Scope

• The report provides wound care management information broken down into detailed categories in the Asia Pacific.
• Total revenues, products sold and end users.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the wound care management market in Asia Pacific.
• Evaluate and compare the attractiveness of the market in the region.
• Identify growth segments and opportunities in each industry sector within the region.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
• Analyze the competitiveness of the market in the region and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the region.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the region.

Table of Contents:

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets Covered in the Report 14
3.1 Wound Care Management 14
3.2 Traditional Wound Management 14
3.3 Advanced Wound Management 14
3.3.1 Semi-Permeable Film 14
3.3.2 Foams 14
3.3.3 Hydrofibres 14
3.3.4 Hydrocolloids 14
3.3.5 Hydrogels 14
3.3.6 Alginates 14
3.3.7 Collagens 14
3.3.8 Negative Pressure Wound Therapy (NPWT) 14
3.4 Wound Closure Devices 15
3.4.1 Hemostats 15
3.4.2 Tissue Sealants 15
3.4.3 Skin Closure Devices 15
3.5 Ostomy 15
3.6 Compression Therapy 15
4 Wound Care Management in Asia Pacific 16
4.1 Wound Care Management, Asia Pacific, Overall Revenues ($ mn), 2000-2012 16
4.2 Wound Care Management, Asia Pacific, Category Volume (Units), 2000-2012 20
4.3 Wound Care Management, Asia Pacific, Company Share (2006-2007) 23
5 Wound Care Management In Japan 24
5.1 Wound Care Management, Japan, Overall Revenues ($ mn), 2000-2012 24
5.2 Wound Care Management, Japan, Category Volume (Units), 2000-2012 28
5.3 Wound Care Management, Japan, Distribution Share (2006-2007) 31
5.3.1 Advanced Wound Management Distribution Share (2006-2007) 31
5.3.2 Compression Therapy Distribution Share (2006-2007) 31
5.3.3 Ostomy Distribution Share (2006-2007) 32
5.3.4 Traditional Wound Management Distribution Share (2006-2007) 32
5.3.5 Wound Closure Devices Distribution Share (2006-2007) 33
5.4 Wound Care Management, Japan, Company Share (2006-2007) 34
5.4.1 Wound Care Management, Japan, Company Share (2006-2007) 34
5.4.2 Advanced Wound Management, Japan, Company Share (2006-2007) 35
5.4.3 Compression Therapy, Japan, Company Share (2006-2007) 36
5.4.4 Ostomy, Japan, Company Share (2006-2007) 37
5.4.5 Traditional Wound Management, Japan, Company Share (2006-2007) 38
5.4.6 Wound Closure Devices, Japan, Company Share (2006-2007) 39
6 Wound Care Management In China 40
6.1 Wound Care Management, China, Overall Revenues ($ mn), 2000-2012 40
6.2 Wound Care Management, China, Category Volume (Units), 2000-2012 44
6.3 Wound Care Management, China, Distribution Share (2006-2007) 47
6.3.1 Advanced Wound Management Distribution Share (2006-2007) 47
6.3.2 Compression Therapy Distribution Share (2006-2007) 47
6.3.3 Ostomy Distribution Share (2006-2007) 48
6.3.4 Traditional Wound Management Distribution Share (2006-2007) 48
6.3.5 Wound Closure Devices Distribution Share (2006-2007) 49
6.4 Wound Care Management, China, Company Share (2006-2007) 50
6.4.1 Wound Care Management, China, Company Share (2006-2007) 50
6.4.2 Advanced Wound Management, China, Company Share (2006-2007) 51
6.4.3 Compression Therapy, China, Company Share (2006-2007) 52
6.4.4 Ostomy, China, Company Share (2006-2007) 53
6.4.5 Traditional Wound Management, China, Company Share (2006-2007) 54
6.4.6 Wound Closure Devices, China, Company Share (2006-2007) 55
7 Wound Care Management In Australia 56
7.1 Wound Care Management, Australia, Overall Revenues ($ mn), 2000-2012 56
7.2 Wound Care Management, Australia, Category Volume (Units), 2000-2012 60
7.3 Wound Care Management, Australia, Distribution Share (2006-2007) 63
7.3.1 Advanced Wound Management Distribution Share (2006-2007) 63
7.3.2 Compression Therapy Distribution Share (2006-2007) 63
7.3.3 Ostomy Distribution Share (2006-2007) 64
7.3.4 Traditional Wound Management Distribution Share (2006-2007) 64
7.3.5 Wound Closure Devices Distribution Share (2006-2007) 65
7.4 Advanced Wound Management, Australia, Company Share (2006-2007) 66
7.4.1 Advanced Wound Management, Australia, Company Share (2006-2007) 66
7.4.2 Compression Therapy, Australia, Company Share (2006-2007) 67
7.4.3 Ostomy, Australia, Company Share (2006-2007) 68
7.4.4 Traditional Wound Management, Australia, Company Share (2006-2007) 69
7.4.5 Wound Closure Devices, Australia, Company Share (2006-2007) 70
8 Wound Care Management In India 71
8.1 Wound Care Management, India, Overall Revenues ($ mn), 2000-2012 71
8.2 Wound Care Management, India, Category Volume (Units), 2000-2012 75
8.3 Wound Care Management, India, Distribution Share (2006-2007) 78
8.3.1 Advanced Wound Management Distribution Share (2006-2007) 78
8.3.2 Compression Therapy Distribution Share (2006-2007) 78
8.3.3 Ostomy Distribution Share (2006-2007) 79
8.3.4 Traditional Wound Management Distribution Share (2006-2007) 79
8.3.5 Wound Closure Devices Distribution Share (2006-2007) 80
8.4 Wound Care Management, India, Company Share (2006-2007) 81
8.4.1 Wound Care Management, India, Company Share (2006-2007) 81
8.4.2 Advanced Wound Management, India, Company Share (2006-2007) 82
8.4.3 Compression Therapy, India, Company Share (2006-2007) 83
8.4.4 Ostomy, India, Company Share (2006-2007) 84
8.4.5 Traditional Wound Management, India, Company Share (2006-2007) 85
8.4.6 Wound Closure Devices, India, Company Share (2006-2007) 86
9 Baxter International Inc. Company Profile 87
9.1 Company Overview 87
9.2 Value Chain Analysis 87
9.2.1 Manufacturing 88
9.2.2 Product Development 88
9.2.3 Sales and Marketing 89
9.2.4 Baxter International Inc. Pipeline Products By Equipment Type 89
9.2.5 Baxter International Inc. Pipeline Products By Development Stage 89
9.2.6 Baxter International Inc. Pipeline Products By Therapy Area 90
9.2.7 Baxter International Inc. Pipeline Products By Clinical Trials 90
9.2.8 Baxter International Inc. Pipeline Products By News Summary 90
10 Covidien Ltd. Company Profile 91
10.1 Company Overview 91
10.2 Value Chain Analysis 91
10.2.1 Manufacturing 92
10.2.2 Product Development 92
10.2.3 Sales and Marketing 93
10.2.4 Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type 93
10.2.5 Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage 93
10.2.6 Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area 94
10.2.7 Covidien Ltd./Tyco Healthcare Pipeline Products By Clinical Trials 94
10.2.8 Covidien Ltd./Tyco Healthcare Pipeline Products By News Summary 94
11 3M Company Company Profile 95
11.1 Company Overview 95
11.2 Value Chain Analysis 95
11.2.1 Manufacturing 96
11.2.2 Product Development 96
11.2.3 Sales and Marketing 97
12 Coloplast A/S Company Profile 98
12.1 Company Overview 98
12.2 Value Chain Analysis 98
12.2.1 Manufacturing 99
12.2.2 Product Development 99
12.2.3 Sales and Marketing 100
13 Ethicon, Inc. Company Profile 101
13.1 Company Overview 101
13.1.1 Ethicon, Inc. Pipeline Products By Equipment Type 101
13.1.2 Ethicon, Inc. Pipeline Products By Development Stage 101
13.1.3 Ethicon, Inc. Pipeline Products By Therapy Area 101
13.1.4 Ethicon, Inc. Pipeline Products By Clinical Trials 101
14 Smith & Nephew Plc Company Profile 102
14.1 Company Overview 102
14.2 Value Chain Analysis 102
14.2.1 Manufacturing 103
14.2.2 Product Development 103
14.2.3 Sales and Marketing 104
14.3 Smith & Nephew Plc Pipeline Products 105
14.3.1 Smith & Nephew Plc Pipeline Products By Equipment Type 105
14.3.2 Smith & Nephew Plc Pipeline Products By Development Stage 105
14.3.3 Smith & Nephew Plc Pipeline Products By Therapy Area 106
15 ConvaTec Company Profile 107
15.1 Company Overview 107
16 HARTMANN GROUP Company Profile 108
16.1 Company Overview 108
16.2 Value Chain Analysis 108
16.2.1 Manufacturing 109
16.2.2 Product Development 109
16.2.3 Sales and Marketing 109
17 Nycomed International Management GmbH Company Profile 110
17.1 Company Overview 110
17.1.1 Nycomed International Management GmbH Pipeline Products By Equipment Type 110
17.1.2 Nycomed International Management GmbH Pipeline Products by Development Stage 110
18 Recent Developments 111
18.1 Product News 111
18.1.1 Sep 08, 2008: Smith & Nephew Announced Agreement with Coloplast to Launch REPLICARE Hydrocolloid Dressing In Japan 111
18.1.2 Jul 21, 2008: Chinese SFDA Approves Helicon Group’s ReCell Concept and Kit 111
18.1.3 Jul 17, 2008: BioElectronics Announces Distribution Agreement For Sales In India 111
19 APPENDIX 112
19.1 Methodology 112
19.2 Coverage 113
19.3 Secondary Research 113
19.4 Primary Research 114
19.5 Models 114
19.6 Forecasts 115
19.7 Expert Panels 115
19.8 Currency Conversion 116
19.9 Contact Us 117
19.10 Disclaimer 117

1.1 List of Tables
Table 1: Wound Care Management, Asia Pacific, Overall Revenues ($ mn), 2000-2012 16
Table 2: Asia Pacific, Wound Care Management, Portfolio Analysis, 2000-2012 17
Table 3: Wound Care Management, Asia Pacific, Overall Revenues ($ mn), Historic, 2000-2007 18
Table 4: Wound Care Management, Asia Pacific, Overall Revenues ($ mn), Forecast, 2007-2012 19
Table 5: Wound Care Management, Asia Pacific, Category Volume (Units), 2000-2012 20
Table 6: Wound Care Management, Asia Pacific, Category Volume (Units), Historic, 2000-2007 21
Table 7: Table 8: Wound Care Management, Asia Pacific, Category Volume (Units), Forecast, 2007-2012 22
Table 9: Wound Care Management, Asia Pacific, Company Share (%), 2007 23
Table 10: Wound Care Management, Japan, Overall Revenues ($ mn), 2000-2012 24
Table 11: Wound Care Management, Japan, Portfolio Analysis, 2000-2012 25
Table 12: Wound Care Management, Japan, Overall Revenues ($ mn), Historic, 2000-2007 26
Table 13: Wound Care Management, Japan, Overall Revenues ($ mn), Forecast, 2007-2012 27
Table 14: Wound Care Management, Japan, Category Volume (Units), 2000-2012 28
Table 15: Wound Care Management, Japan, Category Volume (Units), Historic, 2000-2007 29
Table 16: Wound Care Management, Japan, Category Volume (Units), Forecast, 2007-2012 30
Table 17: Advanced Wound Management, Japan, Distribution Share by Revenue ($mn), 2006-2007 31
Table 18: Compression Therapy, Japan, Distribution Share by Revenue ($mn), 2006-2007 31
Table 19: Ostomy, Japan, Distribution Share by Revenue ($mn), 2006-2007 32
Table 20: Traditional Wound Management, Japan, Distribution Share by Revenue ($mn), 2006-2007 32
Table 21: Wound Closure Devices, Japan, Distribution Share by Revenue ($mn), 2006-2007 33
Table 22: Wound Care Management, Japan, Company Share by Revenue ($ mn), 2006-2007 34
Table 23: Advanced Wound Management, Japan, Company Share by Revenue ($ mn), 2006-2007 35
Table 24: Compression Therapy, Japan, Company Share by Revenue ($ mn), 2006-2007 36
Table 25: Ostomy, Japan, Company Share by Revenue ($ mn), 2006-2007 37
Table 26: Traditional Wound Management, Japan, Company Share by Revenue ($ mn), 2006-2007 38
Table 27: Wound Closure Devices, Japan, Company Share by Revenue ($ mn), 2006-2007 39
Table 28: Wound Care Management, China, Overall Revenues ($ mn), 2000-2012 40
Table 29: Wound Care Management, China, Portfolio Analysis, 2000-2012 41
Table 30: Wound Care Management, China, Overall Revenues ($ mn), Historic, 2000-2007 42
Table 31: Wound Care Management, China, Overall Revenues ($ mn), Forecast, 2007-2012 43
Table 32: Wound Care Management, China, Category Volume (Units), 2000-2012 44
Table 33: Wound Care Management, China, Category Volume (Units), Historic, 2000-2007 45
Table 34: Wound Care Management, China, Category Volume (Units), Forecast, 2007-2012 46
Table 35: Advanced Wound Management, China, Distribution Share by Revenue ($mn), 2006-2007 47
Table 36: Compression Therapy, China, Distribution Share by Revenue ($mn), 2006-2007 47
Table 37: Ostomy, China, Distribution Share by Revenue ($mn), 2006-2007 48
Table 38: Traditional Wound Management, China, Distribution Share by Revenue ($mn), 2006-2007 48
Table 39: Wound Closure Devices, China, Distribution Share by Revenue ($mn), 2006-2007 49
Table 40: Wound Care Management, China, Company Share by Revenue ($ mn), 2006-2007 50
Table 41: Advanced Wound Management, China, Company Share by Revenue ($ mn), 2006-2007 51
Table 42: Compression Therapy, China, Company Share by Revenue ($ mn), 2006-2007 52
Table 43: Ostomy, China, Company Share by Revenue ($ mn), 2006-2007 53
Table 44: Traditional Wound Management, China, Company Share by Revenue ($ mn), 2006-2007 54
Table 45: Wound Closure Devices, China, Company Share by Revenue ($ mn), 2006-2007 55
Table 46: Wound Care Management, Australia, Overall Revenues ($ mn), 2000-2012 56
Table 47: Wound Care Management, Australia, Portfolio Analysis, 2000-2012 57
Table 48: Wound Care Management, Australia, Overall Revenues ($ mn), Historic, 2000-2007 58
Table 49: Wound Care Management, Australia, Overall Revenues ($ mn), Forecast, 2007-2012 59
Table 50: Wound Care Management, Australia, Category Volume (Units), 2000-2012 60
Table 51: Wound Care Management, Australia, Category Volume (Units), Historic, 2000-2007 61
Table 52: Wound Care Management, Australia, Category Volume (Units), Forecast, 2007-2012 62
Table 53: Advanced Wound Management, Australia, Distribution Share by Revenue ($mn), 2006-2007 63
Table 54: Compression Therapy, Australia, Distribution Share by Revenue ($mn), 2006-2007 63
Table 55: Ostomy, Australia, Distribution Share by Revenue ($mn), 2006-2007 64
Table 56: Traditional Wound Management, Australia, Distribution Share by Revenue ($mn), 2006-2007 64
Table 57: Wound Closure Devices, Australia, Distribution Share by Revenue ($mn), 2006-2007 65
Table 58: Advanced Wound Management, Australia, Company Share by Revenue ($ mn), 2006-2007 66
Table 59: Compression Therapy, Australia, Company Share by Revenue ($ mn), 2006-2007 67
Table 60: Ostomy, Australia, Company Share by Revenue ($ mn), 2006-2007 68
Table 61: Traditional Wound Management, Australia, Company Share by Revenue ($ mn), 2006-2007 69
Table 62: Wound Closure Devices, Australia, Company Share by Revenue ($ mn), 2006-2007 70
Table 63: Wound Care Management, India, Overall Revenues ($ mn), 2000-2012 71
Table 64: Wound Care Management, India, Portfolio Analysis, 2000-2012 72
Table 65: Wound Care Management, India, Overall Revenues ($ mn), Historic, 2000-2007 73
Table 66: Wound Care Management, India, Overall Revenues ($ mn), Forecast, 2007-2012 74
Table 67: Wound Care Management, India, Category Volume (Units), 2000-2012 75
Table 68: Wound Care Management, India, Category Volume (Units), Historic, 2000-2007 76
Table 69: Wound Care Management, India, Category Volume (Units), Forecast, 2007-2012 77
Table 70: Advanced Wound Management, India, Distribution Share by Revenue ($mn), 2006-2007 78
Table 71: Compression Therapy, India, Distribution Share by Revenue ($mn), 2006-2007 78
Table 72: Ostomy, India, Distribution Share by Revenue ($mn), 2006-2007 79
Table 73: Traditional Wound Management, India, Distribution Share by Revenue ($mn), 2006-2007 79
Table 74: Wound Closure Devices, India, Distribution Share by Revenue ($mn), 2006-2007 80
Table 75: Wound Care Management, India, Company Share by Revenue ($ mn), 2006-2007 81
Table 76: Advanced Wound Management, India, Company Share by Revenue ($ mn), 2006-2007 82
Table 77: Compression Therapy, India, Company Share by Revenue ($ mn), 2006-2007 83
Table 78: Ostomy, India, Company Share by Revenue ($ mn), 2006-2007 84
Table 79: Traditional Wound Management, India, Company Share by Revenue ($ mn), 2006-2007 85
Table 80: Wound Closure Devices, India, Company Share by Revenue ($ mn), 2006-2007 86
Table 81: Baxter International Inc. Pipeline Products by Equipment Type 89
Table 82: Baxter International Inc. Pipeline Products By Development Stage 89
Table 83: Baxter International Inc. Pipeline Products By Therapy Area 90
Table 84: Baxter International Inc. Pipeline Products By Clinical Trials 90
Table 85: Baxter International Inc. Pipeline Products By News Summaries 90
Table 86: Covidien Ltd./Tyco Healthcare Pipeline Products by Equipment Type 93
Table 87: Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage 93
Table 88: Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area 94
Table 89: Covidien Ltd./Tyco Healthcare Pipeline Products By Clinical Trials 94
Table 90: Covidien Ltd./Tyco Healthcare Pipeline Products By News Summaries 94
Table 91: Ethicon, Inc. Pipeline Products by Equipment Type 101
Table 92: Ethicon, Inc. Pipeline Products By Development Stage 101
Table 93: Ethicon, Inc. Pipeline Products By Therapy Area 101
Table 94: Ethicon, Inc. Pipeline Products By Clinical Trials 101
Table 95: Smith & Nephew Plc Pipeline Products by Equipment Type 105
Table 96: Smith & Nephew Plc Pipeline Products By Development Stage 105
Table 97: Smith & Nephew Plc Pipeline Products By Therapy Area 106
Table 98: Nycomed International Management GmbH Pipeline Products by Equipment Type 110
Table 99: Nycomed International Management GmbH Pipeline Products by Development Stage 110
Table 100: Currency Conversion from USD to Local Currency at 2007 Constant Rate 116

1.2 List of Figures
Figure 1: Wound Care Management, Asia Pacific, Overall Revenues ($ mn), 2000-2012 16
Figure 2: Asia Pacific, Wound Care Management, Portfolio Analysis, 2000-2012 17
Figure 3: Wound Care Management, Asia Pacific, Overall Revenues ($ mn), Historic, 2000-2007 18
Figure 4: Wound Care Management, Asia Pacific, Overall Revenues ($ mn), Forecast, 2007-2012 19
Figure 5: Wound Care Management, Asia Pacific, Category Volume (Units), 2000-2012 20
Figure 6: Wound Care Management, Asia Pacific, Category Volume (Units), Historic, 2000-2007 21
Figure 7: Wound Care Management, Asia Pacific, Category Volume (Units), Forecast, 2007-2012 22
Figure 8: Wound Care Management, Asia Pacific, Company Share (%), 2007 23
Figure 9: Wound Care Management, Japan, Overall Revenues ($ mn), 2000-2012 24
Figure 10: Wound Care Management, Japan, Portfolio Analysis, 2000-2012 25
Figure 11: Wound Care Management, Japan, Overall Revenues ($ mn), Historic, 2000-2007 26
Figure 12: Wound Care Management, Japan, Overall Revenues ($ mn), Forecast, 2007-2012 27
Figure 13: Wound Care Management, Japan, Category Volume (Units), 2000-2012 28
Figure 14: Wound Care Management, Japan, Category Volume (Units), Historic, 2000-2007 29
Figure 15: Wound Care Management, Japan, Category Volume (Units), Forecast, 2007-2012 30
Figure 16: Wound Care Management, Japan, Company Share (%), 2007 34
Figure 17: Advanced Wound Management, Japan, Company Share (%), 2007 35
Figure 18: Compression Therapy, Japan, Company Share (%), 2007 36
Figure 19: Ostomy, Japan, Company Share (%), 2007 37
Figure 20: Traditional Wound Management, Japan, Company Share (%), 2007 38
Figure 21: Wound Closure Devices, Japan, Company Share (%), 2007 39
Figure 22: Wound Care Management, China, Overall Revenues ($ mn), 2000-2012 40
Figure 23: Wound Care Management, China, Portfolio Analysis, 2000-2012 41
Figure 24: Wound Care Management, China, Overall Revenues ($ mn), Historic, 2000-2007 42
Figure 25: Wound Care Management, China, Overall Revenues ($ mn), Forecast, 2007-2012 43
Figure 26: Wound Care Management, China, Category Volume (Units), 2000-2012 44
Figure 27: Wound Care Management, China, Category Volume (Units), Historic, 2000-2007 45
Figure 28: Wound Care Management, China, Category Volume (Units), Forecast, 2007-2012 46
Figure 29: Wound Care Management, China, Company Share (%), 2007 50
Figure 30: Advanced Wound Management, China, Company Share (%), 2007 51
Figure 31: Compression Therapy, China, Company Share (%), 2007 52
Figure 32: Ostomy, China, Company Share (%), 2007 53
Figure 33: Traditional Wound Management, China, Company Share (%), 2007 54
Figure 34: Wound Closure Devices, China, Company Share (%), 2007 55
Figure 35: Wound Care Management, Australia, Overall Revenues ($ mn), 2000-2012 56
Figure 36: Wound Care Management, Australia, Portfolio Analysis, 2000-2012 57
Figure 37: Wound Care Management, Australia, Overall Revenues ($ mn), Historic, 2000-2007 58
Figure 38: Wound Care Management, Australia, Overall Revenues ($ mn), Forecast, 2007-2012 59
Figure 39: Wound Care Management, Australia, Category Volume (Units), 2000-2012 60
Figure 40: Wound Care Management, Australia, Category Volume (Units), Historic, 2000-2007 61
Figure 41: Wound Care Management, Australia, Category Volume (Units), Forecast, 2007-2012 62
Figure 42: Advanced Wound Management, Australia, Company Share (%), 2007 66
Figure 43: Compression Therapy, Australia, Company Share (%), 2007 67
Figure 44: Ostomy, Australia, Company Share (%), 2007 68
Figure 45: Traditional Wound Management, Australia, Company Share (%), 2007 69
Figure 46: Wound Closure Devices, Australia, Company Share (%), 2007 70
Figure 47: Wound Care Management, India, Overall Revenues ($ mn), 2000-2012 71
Figure 48: Wound Care Management, India, Portfolio Analysis, 2000-2012 72
Figure 49: Wound Care Management, India, Overall Revenues ($ mn), Historic, 2000-2007 73
Figure 50: Wound Care Management, India, Overall Revenues ($ mn), Forecast, 2007-2012 74
Figure 51: Wound Care Management, India, Category Volume (Units), 2000-2012 75
Figure 52: Wound Care Management, India, Category Volume (Units), Historic, 2000-2007 76
Figure 53: Wound Care Management, India, Category Volume (Units), Forecast, 2007-2012 77
Figure 54: Wound Care Management, India, Company Share (%), 2007 81
Figure 55: Advanced Wound Management, India, Company Share (%), 2007 82
Figure 56: Compression Therapy, India, Company Share (%), 2007 83
Figure 57: Ostomy, India, Company Share (%), 2007 84
Figure 58: Traditional Wound Management, India, Company Share (%), 2007 85
Figure 59: Wound Closure Devices, India, Company Share (%), 2007 86
Figure 60: Baxter International Inc. Value Chain Analysis 87
Figure 61: Covidien Ltd./Tyco Healthcare Value Chain Analysis 91
Figure 62: 3M Healthcare Value Chain Analysis 95
Figure 63: Coloplast A/S Value Chain Analysis 98
Figure 64: Smith & Nephew Plc Value Chain Analysis 102
Figure 65: Hartmann Group Value Chain Analysis 108
Figure 66: Methodology 112

Related Reports:

Global Wound Care Management Investment Opportunities, Analysis and Forecasts to 2012
India Wound Care Management Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies
Japan Wound Care Management Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies
Wound Care Management Pipeline Product Analysis and Technology Report
Report on Advanced Wound Care Products World Market Segmentation by City 2009
Australia Wound Care Management Investment Opportunities, Analysis and Forecasts to 2012

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/Asia-Pacific-Wound-Care-Management-Investment-Opportunities-Analysis-and-Forecasts-to-2012.html

Or

Contact us at:
Bharat Book Bureau
Tel: +91 22 2757 8668
Fax: +91 22 2757 9131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com

India Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to India wound care management market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management market in India

Scope

- The report provides wound care management information broken down into detailed categories and segments in India.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the wound care management market in India.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents :

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of Markets Covered in This Report 13
3.1 Wound Care Management 13
3.2 Advanced Wound Management 13
3.2.1 Alginates 13
3.2.2 Collagens 13
3.2.3 Foams 13
3.2.4 Hydrocolloids 13
3.2.5 Hydrofibres 13
3.2.6 Hydrogels 13
3.2.7 Negative Pressure Wound Therapy (NPWT) 13
3.2.8 Semi-Permeable Films 13
3.3 Compression Therapy 13
3.4 Ostomy 14
3.5 Traditional Wound Management 14
3.6 Wound Closure Devices 14
3.6.1 Skin Closure Devices 14
3.6.2 Tissue Sealants 14
4 Healthcare Sector Review 15
4.1 Healthcare Expenditure 15
4.2 Healthcare Infrastructure 17
4.2.1 Healthcare Personnel Data 18
4.2.2 Healthcare Facilities Data 19
4.3 Healthcare Policy 20
5 Regulation System 21
5.1 Medical Equipment Approval 21
5.2 Central Drugs Authority of India (CDAI) 22
5.3 Medical Device Regulatory Authority of India (MDRAI) 22
5.4 Classification of medical devices 22
5.4.1 Registration Period 23
6 Pricing and Reimbursement 24
6.1 Pricing and Reimbursement 24
7 Distribution Structure 25
7.1 Distribution Structure 25
8 Wound Care Management In India 26
8.1 Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015 26
8.2 Wound Care Management, India, Overall Revenue ($ mn), 2000-2015 27
8.3 Wound Care Management, India, Category Volume (Units), 2000-2015 31
8.4 Wound Care Management, India, Company Share (2006-2007) 36
9 Advanced Wound Management In India 37
9.1 Advanced Wound Management Overall Revenue (2000-2015) 37
9.2 Advanced Wound Management Overall Volume (2000-2015) 41
9.3 Advanced Wound Management Average Price (2000-2015) 43
9.4 Advanced Wound Management Distribution Share (2007-2008) 44
9.5 Advanced Wound Management, India, Company Share (2006-2007) 45
10 Compression Therapy In India 46
10.1 Compression Therapy Overall Revenue (2000-2015) 46
10.2 Compression Therapy Overall Volume (2000-2015) 48
10.3 Compression Therapy Average Price (2000-2015) 50
10.4 Compression Therapy Distribution Share (2007-2008) 50
10.5 Compression Therapy, India, Company Share (2006-2007) 51
11 Ostomy In India 52
11.1 Ostomy Overall Revenue (2000-2015) 52
11.2 Ostomy Overall Volume (2000-2015) 54
11.3 Ostomy Average Price (2000-2015) 56
11.4 Ostomy Distribution Share (2007-2008) 56
11.5 Ostomy, India, Company Share (2006-2007) 57
12 Traditional Wound Management In India 58
12.1 Traditional Wound Management Overall Revenue (2000-2015) 58
12.2 Traditional Wound Management Overall Volume (2000-2015) 60
12.3 Traditional Wound Management Average Price (2000-2015) 62
12.4 Traditional Wound Management Distribution Share (2007-2008) 62
12.5 Traditional Wound Management, India, Company Share (2006-2007) 63
13 Wound Closure Devices In India 64
13.1 Wound Closure Devices Overall Revenue (2000-2015) 64
13.2 Wound Closure Devices Overall Volume (2000-2015) 66
13.3 Wound Closure Devices Average Price (2000-2015) 68
13.4 Wound Closure Devices Distribution Share (2007-2008) 69
13.5 Wound Closure Devices, India, Company Share (2006-2007) 70
14 Overview of Key Companies in India Wound Care Management Market 71
14.1 Baxter International Inc. 71
14.1.1 Company Overview 71
14.1.2 Value Chain Analysis 72
14.1.2.1 Manufacturing 72
14.1.2.2 Product Development 72
14.1.2.3 Sales and Marketing 73
14.2 Johnson & Johnson 75
14.2.1 Company Overview 75
14.2.2 Value Chain Analysis 75
14.2.2.1 Manufacturing 76
14.2.2.2 Product Development 76
14.2.2.3 Sales and Marketing 77
14.3 Ethicon, Inc. 78
14.3.1 Company Overview 78
14.3.2 Ethicon, Inc. Pipeline Products 78
14.3.2.1 Ethicon, Inc. Pipeline Products By Equipment Type 78
14.3.2.2 Ethicon, Inc. Pipeline Products By Development Stage 78
14.3.2.3 Ethicon, Inc. Pipeline Products By Therapy Area 79
14.3.2.4 Ethicon, Inc. Pipeline Products By Clinical Trials 79
14.4 Smith & Nephew Plc 79
14.4.1 Company Overview 79
14.4.2 Value Chain Analysis 80
14.4.2.1 Manufacturing 80
14.4.2.2 Product Development 81
14.4.2.3 Sales and Marketing 82
14.4.3 Smith & Nephew Plc Pipeline Products 82
14.4.3.1 Smith & Nephew Plc Pipeline Products By Equipment Type 82
14.4.3.2 Smith & Nephew Plc Pipeline Products By Development Stage 83
14.4.3.3 Smith & Nephew Plc Pipeline Products By Therapy Area 83
14.4.3.4 Smith & Nephew Plc Pipeline Products By News Summary 84
14.5 Coloplast A/S 85
14.5.1 Company Overview 85
14.5.2 Value Chain Analysis 85
14.5.2.1 Manufacturing 86
14.5.2.2 Product Development 86
14.5.2.3 Sales and Marketing 87
14.6 Covidien Ltd. 88
14.6.1 Company Overview 88
14.6.2 Value Chain Analysis 89
14.6.2.1 Manufacturing 89
14.6.2.2 Product Development 90
14.6.2.3 Sales and Marketing 91
14.7 ConvaTec 91
14.7.1 Company Overview 91
14.8 HARTMANN GROUP 92
14.8.1 Company Overview 92
14.8.2 Value Chain Analysis 92
14.8.2.1 Manufacturing 93
14.8.2.2 Product Development 93
14.8.2.3 Sales and Marketing 93
14.9 Lakhani Medicare Pvt. Ltd. 94
14.9.1 Company Overview 94
14.10 Hospital Equipment Manufacturing 94
14.10.1 Company Overview 94
14.11 Eucare Pharmaceuticals (P) Ltd. 94
14.11.1 Company Overview 94
15 Financial Deals Landscape 95
15.1 Partnerships 95
15.1.1 Angiotech Pharmaceuticals Enters Into An Agreement With Baxter International 95
16 Appendix 96
16.1 Global Markets Direct Research Methodology 96
16.2 Coverage 97
16.3 Secondary Research 97
16.4 Primary Research 98
16.5 Models 98
16.6 Forecasts 99
16.7 Expert Panel Validation 99
16.8 Currency Conversion 100
16.9 Contact Us 101
16.10 Disclaimer 101

1.1 List of Tables
Table 1: Number of Doctors by Specialty in India, 2000-2006 18
Table 2: Wards by Specialty in India, 2000-2006 19
Table 3: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015 26
Table 4: Wound Care Management, India, Overall Revenue ($ mn), 2000-2015 27
Table 5: Wound Care Management, India, Cross-Category Analysis, 2000-2015 28
Table 6: Wound Care Management, India, Overall Revenue ($ mn), Historic, 2000-2008 29
Table 7: Wound Care Management, India, Overall Revenue ($ mn), Forecast, 2008-2015 30
Table 8: Wound Care Management, India, Category Volume (Units), 2000-2015 31
Table 9: Wound Care Management, India, Category Volume (Units), Historic, 2000-2008 33
Table 10: Wound Care Management, India, Category Volume (Units), Forecast, 2008-2015 35
Table 11: Wound Care Management, India, Company Share by Revenue ($ mn), 2006-2007 36
Table 12: Advanced Wound Management, India, Revenue ($ mn) by Segment, Historic, 2000-2008 38
Table 13: Advanced Wound Management, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 40
Table 14: Advanced Wound Management, India, Volume (Units) by Segment, Historic, 2000-2008 41
Table 15: Advanced Wound Management, India, Volume (Units) by Segment, Forecast, 2008-2015 42
Table 16: Advanced Wound Management, India, Average Price ($), Historic, 2000-2008 43
Table 17: Advanced Wound Management, India, Average Price ($), Forecast, 2008-2015 43
Table 18: Advanced Wound Management, India, Distribution Share by Revenue ($mn), 2007-2008 44
Table 19: Advanced Wound Management, India, Company Share by Revenue ($ mn), 2006-2007 45
Table 20: Compression Therapy, India, Revenue ($ mn), Historic, 2000-2008 46
Table 21: Compression Therapy, India, Revenue ($ mn), Forecast, 2008-2015 47
Table 22: Compression Therapy, India, Volume (Units), Historic, 2000-2008 48
Table 23: Compression Therapy, India, Volume (Units), Forecast, 2008-2015 49
Table 24: Compression Therapy, India, Average Price ($), Historic, 2000-2008 50
Table 25: Compression Therapy, India, Average Price ($), Forecast, 2008-2015 50
Table 26: Compression Therapy, India, Distribution Share by Revenue ($mn), 2007-2008 50
Table 27: Compression Therapy, India, Company Share by Revenue ($ mn), 2006-2007 51
Table 28: Ostomy, India, Revenue ($ mn), Historic, 2000-2008 52
Table 29: Ostomy, India, Revenue ($ mn), Forecast, 2008-2015 53
Table 30: Ostomy, India, Volume (Units), Historic, 2000-2008 54
Table 31: Ostomy, India, Volume (Units), Forecast, 2008-2015 55
Table 32: Ostomy, India, Average Price ($), Historic, 2000-2008 56
Table 33: Ostomy, India, Average Price ($), Forecast, 2008-2015 56
Table 34: Ostomy, India, Distribution Share by Revenue ($mn), 2007-2008 56
Table 35: Ostomy, India, Company Share by Revenue ($ mn), 2006-2007 57
Table 36: Traditional Wound Management, India, Revenue ($ mn), Historic, 2000-2008 58
Table 37: Traditional Wound Management, India, Revenue ($ mn), Forecast, 2008-2015 59
Table 38: Traditional Wound Management, India, Volume (Units), Historic, 2000-2008 60
Table 39: Traditional Wound Management, India, Volume (Units), Forecast, 2008-2015 61
Table 40: Traditional Wound Management, India, Average Price ($), Historic, 2000-2008 62
Table 41: Traditional Wound Management, India, Average Price ($), Forecast, 2008-2015 62
Table 42: Traditional Wound Management, India, Distribution Share by Revenue ($mn), 2007-2008 62
Table 43: Traditional Wound Management, India, Company Share by Revenue ($ mn), 2006-2007 63
Table 44: Wound Closure Devices, India, Revenue ($ mn) by Segment, Historic, 2000-2008 64
Table 45: Wound Closure Devices, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 65
Table 46: Wound Closure Devices, India, Volume (Units) by Segment, Historic, 2000-2008 66
Table 47: Wound Closure Devices, India, Volume (Units) by Segment, Forecast, 2008-2015 67
Table 48: Wound Closure Devices, India, Average Price ($), Historic, 2000-2008 68
Table 49: Wound Closure Devices, India, Average Price ($), Forecast, 2008-2015 68
Table 50: Wound Closure Devices, India, Distribution Share by Revenue ($mn), 2007-2008 69
Table 51: Wound Closure Devices, India, Company Share by Revenue ($ mn), 2006-2007 70
Table 52: Ethicon, Inc. Pipeline Products by Equipment Type 78
Table 53: Ethicon, Inc. Pipeline Products By Development Stage 78
Table 54: Ethicon, Inc. Pipeline Products By Therapy Area 79
Table 55: Ethicon, Inc. Pipeline Products By Clinical Trials 79
Table 56: Smith & Nephew Plc Pipeline Products by Equipment Type 82
Table 57: Smith & Nephew Plc Pipeline Products By Development Stage 83
Table 58: Smith & Nephew Plc Pipeline Products By Therapy Area 83
Table 59: Smith & Nephew Plc Pipeline Products By News Summary 84
Table 60: Angiotech Pharmaceuticals Enters Into An Agreement With Baxter International 95
Table 61: USD to Local Currency, Average Exchange Rate 2008 100

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in India, 2000-2005 16
Figure 2: Private Expenditure on Health by Source, 2005 17
Figure 3: Proposed Medical Equipment Classification in India, 2005 23
Figure 4: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015 26
Figure 5: Wound Care Management, India, Overall Revenue ($ mn), 2000-2015 27
Figure 6: Wound Care Management, India, Cross-Category Analysis, 2000-2015 28
Figure 7: Wound Care Management, India, Overall Revenue ($ mn), Historic, 2000-2008 29
Figure 8: Wound Care Management, India, Overall Revenue ($ mn), Forecast, 2008-2015 30
Figure 9: Wound Care Management, India, Category Volume (Units), 2000-2015 31
Figure 10: Wound Care Management, India, Category Volume (Units), Historic, 2000-2008 32
Figure 11: Wound Care Management, India, Category Volume (Units), Forecast, 2008-2015 34
Figure 12: Wound Care Management, India, Company Share (%), 2007 36
Figure 13: Advanced Wound Management, India, Revenue ($ mn) by Segment, Historic, 2000-2008 37
Figure 14: Advanced Wound Management, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 39
Figure 15: Advanced Wound Management, India, Volume (Units) by Segment, Historic, 2000-2008 41
Figure 16: Advanced Wound Management, India, Volume (Units) by Segment, Forecast, 2008-2015 42
Figure 17: Advanced Wound Management, India, Company Share (%), 2007 45
Figure 18: Compression Therapy, India, Revenue ($ mn), Historic, 2000-2008 46
Figure 19: Compression Therapy, India, Revenue ($ mn), Forecast, 2008-2015 47
Figure 20: Compression Therapy, India, Volume (Units), Historic, 2000-2008 48
Figure 21: Compression Therapy, India, Volume (Units), Forecast, 2008-2015 49
Figure 22: Compression Therapy, India, Company Share (%), 2007 51
Figure 23: Ostomy, India, Revenue ($ mn), Historic, 2000-2008 52
Figure 24: Ostomy, India, Revenue ($ mn), Forecast, 2008-2015 53
Figure 25: Ostomy, India, Volume (Units), Historic, 2000-2008 54
Figure 26: Ostomy, India, Volume (Units), Forecast, 2008-2015 55
Figure 27: Ostomy, India, Company Share (%), 2007 57
Figure 28: Traditional Wound Management, India, Revenue ($ mn), Historic, 2000-2008 58
Figure 29: Traditional Wound Management, India, Revenue ($ mn), Forecast, 2008-2015 59
Figure 30: Traditional Wound Management, India, Volume (Units), Historic, 2000-2008 60
Figure 31: Traditional Wound Management, India, Volume (Units), Forecast, 2008-2015 61
Figure 32: Traditional Wound Management, India, Company Share (%), 2007 63
Figure 33: Wound Closure Devices, India, Revenue ($ mn) by Segment, Historic, 2000-2008 64
Figure 34: Wound Closure Devices, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 65
Figure 35: Wound Closure Devices, India, Volume (Units), Historic, 2000-2008 66
Figure 36: Wound Closure Devices, India, Volume (Units) by Segment, Forecast, 2008-2015 67
Figure 37: Wound Closure Devices, India, Company Share (%), 2007 70
Figure 38: Baxter International Inc. Value Chain Analysis 72
Figure 39: Johnson & Johnson Value Chain Analysis 75
Figure 40: Smith & Nephew Plc Value Chain Analysis 80
Figure 41: Coloplast A/S Value Chain Analysis 85
Figure 42: Covidien Ltd./Tyco Healthcare Value Chain Analysis 89
Figure 43: Hartmann Group Value Chain Analysis 92
Figure 44: Global Markets Direct Methodology 96

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/India-Wound-Care-Management-Investment-Opportunities-Analysis-and-Forecasts.html 

Or

Contact us at:
Bharat Book Bureau
Tel: +91 22 2757 8668
Fax: +91 22 2757 9131
Email: info@bharatbook.com
Website: www.bharatbook.com

“Wound Closure Devices Systems Pipeline Technology and Market Forecasts to 2015” report is an essential source of information and analysis on the global wound closure devices market. The report identifies the key trends shaping and driving the dynamism in the global wound closure devices market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. The report also analyses the M&A landscape in the global wound closure devices market with special focus on the market participants that have been the most M&A active. Most importantly, the report provides valuable insight on the pipeline products within the global wound closure devices sector.

Scope

-Annualized global wound closure devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
-Analysis and review of the key events and milestones that will impact the future of the global wound closure devices market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
-Insightful review of key industry drivers, restraints and challenges which are likely to impact the global wound closure devices market in the long run.
-In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
-The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
-Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
-The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

-Develop business strategies by understanding the trends shaping and driving the global wound closure devices market.
-Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global wound closure devices market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

Table of Contents:

1 Table Of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Wound Closure Devices Pipeline Technology And Market Forecasts To 2015 7
2.1 Wound Closure Devices- Definitions 7
2.1.1 Skin Closure Devices 7
2.1.2 Tissue Sealants 7
2.1.3 Hemostats 7
2.2 Executive Summary 8
3 Wound Closure Devices Technology Landscape 9
3.1 Wound Closure Devices: Overview 9
3.2 Wound Healing 10
3.3 Wound Closure Devices 11
3.3.1 Surgical staples 11
3.3.2 Skin closure tapes/strips 11
3.3.3 Fibrin Sealants 11
3.3.4 Skin adhesives 11
3.4 Wound Closure Devices Clinical Trials 12
4 Global Wound Closure Device Market 13
4.1 Market Overview 13
4.2 Wound Closure Devices: Cross Geography Analysis 15
4.3 Wound Closure Devices Market Trends 17
4.3.1 Wound Closure Devices Market Drivers 17
4.3.2 Wound Closure Devices Market Restraints 17
4.4 Competitive Landscape 18
5 Wound Closure Devices Pipeline Products 20
5.1 Pipeline Products by Geography 20
5.2 Pipeline Products by Development Stage 21
5.3 PleuraSeal Lung Sealant System 22
5.3.1 PleuraSeal Lung Sealant System Product Status 22
5.3.2 PleuraSeal Lung Sealant System Product Description 22
5.3.3 PleuraSeal Lung Sealant System Clinical Trials 23
5.4 TachoSil patch 24
5.4.1 TachoSil patch Product Status 24
5.4.2 TachoSil patch Product Description 24
5.5 Covastat 25
5.5.1 Covastat Product Status 25
5.5.2 Covastat Product Description 25
5.6 PRINEO Skin Closure System 26
5.6.1 PRINEO Skin Closure System Product Status 26
5.6.2 PRINEO Skin Closure System Product Description 26
5.7 CryoSeal Fibrin Sealant System 27
5.7.1 CryoSeal Fibrin Sealant System Product Status 27
5.7.2 CryoSeal Fibrin Sealant System Product Description 27
5.8 Evithorm 28
5.8.1 Evithorm Product Status 28
5.8.2 Evithorm Product Description 28
5.9 Wound Closure Devices Pipeline Products By Territory 29
5.10 Wound Closure Devices Pipeline Products By Development Stage 31
6 Global Wound Closure Devices Pipeline Product Summary 33
7 Global Wound Closure Devices Clinical Trial Summary 36
8 Future Outlook 37
9 Appendix 38
9.1 Research Methodology 38
9.2 Coverage 39
9.3 Secondary Research 39
9.4 Primary Research 40
9.5 Models 40
9.6 Forecasts 41
9.7 Expert Panels 41
9.8 GlobalData Consulting 41
9.9 Contact Us 41
9.10 Disclaimer 42

1.1 List of Tables

Table 1: Wound Closure Devices, Global, Value ($m), 2001 - 2008 14
Table 2: Wound Closure Devices, Global, Value ($m), 2008 - 2015 14
Table 3: Recent Wound Closure Devices Approval, US, 2008 18
Table 4: Key Acquisitions and Agreements in the Wound Closure Devices Market, 2003-2008 19
Table 5:      PleuraSeal Lung Sealant System, Product Status 22
Table 6:      PleuraSeal Lung Sealant System, Product Description 22
Table 7:      PleuraSeal Lung Sealant System Clinical Trial 1 23
Table 8:      TachoSil patch, Product Status 24
Table 9:      TachoSil patch, Product Description 24
Table 10:      Covastat, Product Status 25
Table 11:      Covastat, Product Description 25
Table 12:      PRINEO Skin Closure System, Product Status 26
Table 13:      PRINEO Skin Closure System, Product Description 26
Table 14:      CryoSeal Fibrin Sealant System, Product Status 27
Table 15:      CryoSeal Fibrin Sealant System, Product Description 27
Table 16:      Evithorm, Product Status 28
Table 17:      Evithorm, Product Description 28
Table 18: Wound Closure Devices Pipeline Products By Territory 29
Table 19: Wound Closure Devices Pipeline Products By Development Stage 31
Table 20: Global Wound Closure Devices Pipeline Product Summary 33
Table 21: Wound Closure Devices Pipeline Products By Clinical Trial 36

1.2 List of Figures

Figure 1: Wound Characteristics 9
Figure 2: Phases of Wound Healing 10
Figure 3: Wound Closure Devices, Global. Revenue ($m), 2001-2015 13
Figure 4: Wound Closure Device, Cross Geography Analysis, 2008 15
Figure 5: Wound Closure Devices Pipeline Products by Geography 20
Figure 6: Wound Closure Devices Pipeline Products by Development Stage 21
Figure 7: GlobalData Methodology 38
To know more and to buy a copy of your report please visit
http://www.bharatbook.com/Market-Research-Reports/Wound-Closure-Devices-Pipeline-Technology-and-Market-Forecasts.html